GROWTH PROMOTING PEPTIDES, AND USES THEREOF

20210353707 · 2021-11-18

Assignee

Inventors

Cpc classification

International classification

Abstract

A natural peptide comprising a cellular growth promoting fragment of a protein selected from SEQ ID NOs: 1 to 13, and a composition comprising a plurality of growth promoting peptides, is described. Also disclosed is the use of the peptides and compositions in prevention of ageing of human skin, treatment of diseases or conditions characterised by damaged epithelial cells or tissue such as colon cancer and peripheral inflammatory disorders, and wound treatment. Specific pea and rice protein derived peptides are described in SEQ ID NOs: 15 to 505, and 546 to 704.

Claims

1. (canceled)

2. A peptide of 5 to 50 amino acids in length and comprising a sequence selected from SEQUENCE ID NO: 15-505 and 546-704 and 717-775.

3. The peptide of claim 1, wherein the peptide consists essentially of a sequence selected from SEQUENCE ID NO: 15-505 and 546-704 and 717-775.

4. A composition comprising a peptide of claim 3.

5. A composition comprising a peptide of claim 2.

Description

BRIEF DESCRIPTION OF THE FIGURES

[0298] FIGS. 1 to 100: Effect of synthetic peptides of the invention on proliferation of Human Dermal Fibroblasts (HDF).

[0299] FIG. 101: Effect of synthetic peptide of the invention (SEQ ID NO: 42) on elastin synthesis of Human Dermal Fibroblasts (HDF).

[0300] FIG. 102: Effect of synthetic peptide of the invention (SEQ ID NO: 42) on collagen synthesis of Human Dermal Fibroblasts (HDF).

[0301] FIG. 103: Effect of synthetic peptide of the invention (SEQ ID NO: 701) on elastin synthesis of Human Dermal Fibroblasts (HDF).

[0302] FIG. 104: Effect of synthetic peptide of the invention (SEQ ID NO: 701) on collagen synthesis of Human Dermal Fibroblasts (HDF).

[0303] FIG. 105: Effect of synthetic peptide of the invention (SEQ ID NO: 246) on elastin synthesis of Human Dermal Fibroblasts (HDF).

[0304] FIG. 106: Effect of synthetic peptide of the invention (SEQ ID NO: 246) on collagen synthesis of Human Dermal Fibroblasts (HDF).

[0305] FIG. 107: Effect of synthetic peptide of the invention (SEQ ID NO: 284) on elastin synthesis of Human Dermal Fibroblasts (HDF).

[0306] FIG. 108: Effect of synthetic peptide of the invention (SEQ ID NO: 245) on elastin synthesis of Human Dermal Fibroblasts (HDF).

[0307] FIG. 109: Effect of synthetic peptide of the invention (SEQ ID NO: 245) on collagen synthesis of Human Dermal Fibroblasts (HDF).

[0308] FIG. 110. shows the integrity controls and viability controls for the assay system.

[0309] FIG. 111. % of elastin expression in superficial dermis compared to control (water or DMSO) for peptides P1, P2 and P3

[0310] shows significant increases of elastin expression in superficial AND middle dermis.

[0311] FIG. 112. % of elastin expression in middle dermis compared to control (water or DMSO) for peptides P1, P2 and P3.

[0312] shows significant increases of elastin expression in superficial AND middle dermis.

[0313] FIG. 113. % of cell proliferation in the basal layer of epidermis compared to control (water or DMSO) for peptides P6 and P8, and peptide compositions P9 and P10

[0314] shows significant increases.

[0315] FIG. 114. Histological analysis of the elastic fibers (+catechin, x200)

[0316] FIG. 115. Immunohistochemical evaluation of the mitotic index (Ki67, x400)

DETAILED DESCRIPTION OF THE INVENTION

EXAMPLE 1—CELL PROLIFERATION ASSAY

[0317] BrDu is incorporated into newly synthesised DNA strands of actively proliferating cells. Following partial denaturation of double stranded DNA, Brdu is detected immunochemically allowing the assessment of the population of cells which are synthesizing DNA. Human Dermal Fibroblasts (HDF—Sigma 10605a) were seeded in a 96 well plate at 10,000 cells per well in DMEM containing 10% fetal calf serum (FCS), 1% Pen/strep, 1% L-glutamine and allowed to adhere for 24h.

[0318] Following the initial 24h incubation the cells were incubated with 5 μg/ml, 0.5 μg/m1 or 0.05 μg/m1 synthetic peptide for 24h respectively.

[0319] After 18 h incubation with synthetic peptides 20 μl BrDu reagent was added to each well. At 24h incubation the cell were fixed and the amount of 2-DG6P was measured using the BrdU Cell Proliferation Assay, all steps were carried out according to the manufacturer's instructions.

[0320] Results were calculated as a percentage of the untreated control. An increase in optical density reading indicates greatER incorporation of BrDu and increase cell proliferation. The results are shown in FIGS. 1-100 and Table 1 below.

TABLE-US-00004 TABLE 1 INCREASE INCREASE FIG. SEQ ID IN PROLIFERA- FIG. IN PROLIFERA- NO NO: TION NO SEQ ID TION 1 121 48% 29 98 49% 2 105 40% 30 454 38% 3 249 30% 31 85 35% 4 226 30% 32 453 25% 5 84 20% 33 158 21% 6 330 18% 34 464 18% 7 181 33% 35 73 16% 8 83 32% 36 359 15% 9 247 28% 37 124 15% 10 97 26% 38 112 15% 11 74 29% 39 733 12 40 728 13 168 41 727 14 151 42 730 15 470 119%  43 731 16 257 118%  44 148 17 256 117%  45 343 18 457 114%  46 345 19 499 113%  47 484 20 253 112%  48 729 21 222 110%  49 456 22 272 97% 50 494 23 252 111%  51 723 24 248 86% 52 722 25 472 77% 53 498 26 365 58% 54 475 13% 27 502 68% 55 718 28 496 51% 56 337  8% 57 500  6% 79 463 100%  58 717 80 465 96% 59 297 81 467 90% 60 340 82 461 85% 61 719 83 341 83% 62 726 84 468 82% 63 725 85 285 81% 64 724 86 496 81% 65 720 87 146 80% 66 721 88 478 76% 67 503 125%  89 452 76% 68 474 121%  90 495 68% 69 504 119%  91 403 51% 70 114 119%  92 455 47% 71 505 118%  93 270 47% 72 482 113%  94 501 43% 73 479 106%  95 473 41% 74 477 81% 96 39% 75 410 73% 97 471 38% 76 475 69% 98 460 38% 77 497 58% 99 93 26% 78 480 102%  100 462 15%

[0321] FIG. 1 shows an increase in HGF cell proliferation of 48% when incubated with SEQ ID 121.

[0322] FIG. 2 shows an increase in HGF cell proliferation of 40% when incubated with SEQ ID 105.

[0323] FIG. 3 shows an increase in HGF cell proliferation of 30% when incubated with SEQ ID 249.

[0324] FIG. 4 shows an increase in HGF cell proliferation of 30% when incubated with SEQ ID 226.

[0325] FIG. 5 shows an increase in HGF cell proliferation of 20% when incubated with SEQ ID 84.

[0326] FIG. 6 shows an increase in HGF cell proliferation of 18% when incubated with SEQ ID 330.

[0327] FIG. 7 shows an increase in HGF cell proliferation of 33% when incubated with SEQ ID 181.

[0328] FIG. 8 shows an increase in HGF cell proliferation of 32% when incubated with SEQ ID 83.

[0329] FIG. 9 shows an increase in HGF cell proliferation of 28% when incubated with SEQ ID 247.

[0330] FIG. 10 shows an increase in HGF cell proliferation of 26% when incubated with SEQ ID 97.

[0331] FIG. 11 shows an increase in HGF cell proliferation of 29% when incubated with SEQ ID 74.

[0332] FIG. 15 shows an increase in HGF cell proliferation of 119% when incubated with SEQ ID 470.

[0333] FIG. 16 shows an increase in HGF cell proliferation of 118% when incubated with SEQ ID 257.

[0334] FIG. 17 shows an increase in HGF cell proliferation of 117% when incubated with SEQ ID 256.

[0335] FIG. 18 shows an increase in HGF cell proliferation of 114% when incubated with SEQ ID 457.

[0336] FIG. 19 shows an increase in HGF cell proliferation of 113% when incubated with SEQ ID 499.

[0337] FIG. 20 shows an increase in HGF cell proliferation of 112% when incubated with SEQ ID 253.

[0338] FIG. 21 shows an increase in HGF cell proliferation of 110% when incubated with SEQ ID 222.

[0339] FIG. 22 shows an increase in HGF cell proliferation of 97% when incubated with SEQ ID 272.

[0340] FIG. 23 shows an increase in HGF cell proliferation of 111% when incubated with SEQ ID 252.

[0341] FIG. 24 shows an increase in HGF cell proliferation of 86% when incubated with SEQ ID 248.

[0342] FIG. 25 shows an increase in HGF cell proliferation of 77% when incubated with SEQ ID 472.

[0343] FIG. 26 shows an increase in HGF cell proliferation of 58% when incubated with SEQ ID 365.

[0344] FIG. 27 shows an increase in HGF cell proliferation of 68% when incubated with SEQ ID 502.

[0345] FIG. 28 shows an increase in HGF cell proliferation of 51% when incubated with SEQ ID 496.

[0346] FIG. 29 shows an increase in HGF cell proliferation of 49% when incubated with SEQ ID 98.

[0347] FIG. 30 shows an increase in HGF cell proliferation of 38% when incubated with SEQ ID 454.

[0348] FIG. 31 shows an increase in HGF cell proliferation of 35% when incubated with SEQ ID 85.

[0349] FIG. 32 shows an increase in HGF cell proliferation of 25% when incubated with SEQ ID 453.

[0350] FIG. 33 shows an increase in HGF cell proliferation of 21% when incubated with SEQ ID 158.

[0351] FIG. 34 shows an increase in HGF cell proliferation of 18% when incubated with SEQ ID 464.

[0352] FIG. 35 shows an increase in HGF cell proliferation of 16% when incubated with SEQ ID 73.

[0353] FIG. 36 shows an increase in HGF cell proliferation of 15% when incubated with SEQ ID 359.

[0354] FIG. 37 shows an increase in HGF cell proliferation of 15% when incubated with SEQ ID 124.

[0355] FIG. 38 shows an increase in HGF cell proliferation of 15% when incubated with SEQ ID 112.

[0356] FIG. 54 shows an increase in HGF cell proliferation of 13% when incubated with SEQ ID 475.

[0357] FIG. 56 shows an increase in HGF cell proliferation of 8% when incubated with SEQ ID 337.

[0358] FIG. 57 shows an increase in HGF cell proliferation of 6% when incubated with SEQ ID 500.

[0359] FIG. 67 shows an increase in HGF cell proliferation of 125% when incubated with SEQ ID 503.

[0360] FIG. 68 shows an increase in HGF cell proliferation of 121% when incubated with SEQ ID 474.

[0361] FIG. 69 shows an increase in HGF cell proliferation of 119% when incubated with SEQ ID 504.

[0362] FIG. 70 shows an increase in HGF cell proliferation of 119% when incubated with SEQ ID 114.

[0363] FIG. 71 shows an increase in HGF cell proliferation of 118% when incubated with SEQ ID 505.

[0364] FIG. 72 shows an increase in HGF cell proliferation of 113% when incubated with SEQ ID 482.

[0365] FIG. 73 shows an increase in HGF cell proliferation of 106% when incubated with SEQ ID 479.

[0366] FIG. 74 shows an increase in HGF cell proliferation of 81% when incubated with SEQ ID 477.

[0367] FIG. 75 shows an increase in HGF cell proliferation of 73% when incubated with SEQ ID 410.

[0368] FIG. 76 shows an increase in HGF cell proliferation of 69% when incubated with SEQ ID 475.

[0369] FIG. 77 shows an increase in HGF cell proliferation of 58% when incubated with SEQ ID 497.

[0370] FIG. 78 shows an increase in HGF cell proliferation of 102% when incubated with SEQ ID 480.

[0371] FIG. 79 shows an increase in HGF cell proliferation of 100% when incubated with SEQ ID 463.

[0372] FIG. 80 shows an increase in HGF cell proliferation of 96% when incubated with SEQ ID 465.

[0373] FIG. 81 shows an increase in HGF cell proliferation of 90% when incubated with SEQ ID 467.

[0374] FIG. 82 shows an increase in HGF cell proliferation of 85% when incubated with SEQ ID 461.

[0375] FIG. 83 shows an increase in HGF cell proliferation of 83% when incubated with SEQ ID 341.

[0376] FIG. 84 shows an increase in HGF cell proliferation of 82% when incubated with SEQ ID 468.

[0377] FIG. 85 shows an increase in HGF cell proliferation of 81% when incubated with SEQ ID 485.

[0378] FIG. 86 shows an increase in HGF cell proliferation of 81% when incubated with SEQ ID 496.

[0379] FIG. 87 shows an increase in HGF cell proliferation of 80% when incubated with SEQ ID 146.

[0380] FIG. 88 shows an increase in HGF cell proliferation of 76% when incubated with SEQ ID 478.

[0381] FIG. 89 shows an increase in HGF cell proliferation of 76% when incubated with SEQ ID 452.

[0382] FIG. 90 shows an increase in HGF cell proliferation of 68% when incubated with SEQ ID 495.

[0383] FIG. 91 shows an increase in HGF cell proliferation of 51% when incubated with SEQ ID 403.

[0384] FIG. 92 shows an increase in HGF cell proliferation of 47% when incubated with SEQ ID 455.

[0385] FIG. 93 shows an increase in HGF cell proliferation of 47% when incubated with SEQ ID 270.

[0386] FIG. 94 shows an increase in HGF cell proliferation of 43% when incubated with SEQ ID501.

[0387] FIG. 95 shows an increase in HGF cell proliferation of 41% when incubated with SEQ ID 473.

[0388] FIG. 97 shows an increase in HGF cell proliferation of 38% when incubated with SEQ ID 471.

[0389] FIG. 98 shows an increase in HGF cell proliferation of 38% when incubated with SEQ ID 460.

[0390] FIG. 99 shows an increase in HGF cell proliferation of 26% when incubated with SEQ ID 93.

[0391] FIG. 100 shows an increase in HGF cell proliferation of 15% when incubated with SEQ ID 462.

EXAMPLE 2—COLLAGEN PRODUCTION ASSAY

[0392] Hydroxyproline in tissue preparations is a direct measure of the amount of collagen present. FIRELISA Human Hydroxyproline ELISA kit assay is designed to measure hydroxyproline in tissue or peptide compositions.

[0393] Human Dermal Fibroblasts (HDF Sigma 10605a) were seeded in 24 well plates at 50,000 cells per well in DMEM containing 10% fetal calf serum (FCS), 1% Pen/strep, 1% L-glutamine and allowed to adhere for 24h.

[0394] Following the initial 24h incubation the cells were incubated with 5 μg/ml, 1 μg/m1 or 0.1μg/m1 synthetic peptide for 96h respectively.

[0395] After treatment the cells were lysed using 4 freeze thaw cycles in liquid nitrogen. The lysed cells were centrifuged and 50 μl/ml of each supernatant was assayed using the FIRELISA

[0396] Human Hydroxyproline ELISA kit. All steps were carried out according to the manufacturer's instructions.

[0397] Results were calculated as a percentage of the untreated control. An increase in optical density reading indicates an increase collagen content.

[0398] The results are shown in FIGS. 102, 104, 106 and 109

EXAMPLE 3—ELASTIN PRODUCTION ASSAY

[0399] Elastin is a highly elastic protein in connective tissue and allows many tissues in the body to resume their shape after stretching or contracting. FIRELISA Human Elastin ELISA kit assay is designed to measure Elastin in tissue or protein/peptide compositions.

[0400] Human Dermal Fibroblasts (HDF) were seeded in 24 well plates at 50,000 cells per well in DMEM containing 10% fetal calf serum (FCS), 1% Pen/strep, 1% L-glutamine and allowed to adhere for 24h.

[0401] Following the initial 24h incubation the cells were incubated with 5 μg/ml, 1 μg/m1 or 0.1 μg/ml synthetic peptide for 96h respectively.

[0402] After treatment the cells were lysed using 4 freeze thaw cycles in liquid nitrogen. The lysed cells were centrifuged and 50 μl/ml of each supernatant was assayed using the FIRELISA Human Elastin ELISA kit. All steps were carried out according to the manufacturer's instructions.

[0403] Results were calculated as a percentage of the untreated control. An increase in optical density reading indicates an increase collagen content.

[0404] The results are shown in FIGS. 101, 103, 105, 107, 108 and 109.

EXAMPLE 4—ELASTIN AND CELL PROLIFERATION ASSAYS

[0405]

TABLE-US-00005 TABLE 2 Test items. Peptide 6 and Peptide 7 correspond to samples dissolved into DMSO 0.3% instead of water. Intertek Item Denomination Concentration Provider Nature reference Solubility Storage Peptide 1 E_280_PJ 20 μM Nuritas Peptide 14-CHL- Water −80° C. 0723-01 Peptide 2 I_222two_IN 20 μM Nuritas Peptide 14-CHL- Water Ambient 0723-02 Peptide 3 E_134_two_IN 20 μM Nuritas Peptide 14-CHL- Water −80° C. 0723-03 Peptide 4 E_30two_IN 20 μM Nuritas Peptide 14-CHL- Water −80° C. 0723-04 Peptide 5 E_121two_IN 20 μM Nuritas Peptide 14-CHL- Water −80° C. 0723-05 Peptide 6 I_10two_IN 20 μM Nuritas Peptide 14-CHL- DMSO −80° C. 0723-06 0.3% Peptide 7 I_41two_IN 20 μM Nuritas Peptide 14-CHL- DMSO −80° C. 0723-07 0.3% Peptide 8 E_41_PJ 10 μM* Nuritas Peptide 14-CHL- Water −80° C. 0723-08 Composition P9 E_2_IN 500 μg/mL Nuritas Composition 14-CHL- Water −80° C. of peptides 0723-09 Composition P10 I_2_IN 500 μg/mL Nuritas Composition 14-CHL- Water −80° C. of peptides 0723-10

[0406] Equipment

[0407] Incubator, Flow Laminar Chamber, Sterile Polished Plastic Rod, Pipettor, Maintenance medium, Plate 6 well, Plate 24 well.

[0408] Reagents

[0409] MTT, PBS, SDS, Formaldehyde, Xylene, Ethanol absolute, Dulbecco's phosphate-buffered saline (DPBS), Metal Enhanced DAB substrate kit, ABC peroxidase staining kit, Citric acid, Sodium hydroxide 2N, Hydrogen peroxide 30%, Anti-Filaggrin, Anti-rabbit IgG-Biotin, Tween 20.

[0410] Test system

[0411] Nature: Human skin tissue 5mm diameter

[0412] Batch number: EXP004050B009 and EXP004050B011 Provider: Laboratoire Biopredic International—8-18 rue Jean Pecker—35000 Rennes—France. Tel: +33 (0)2.99.14.36.14 - Fax: +33 (0)2.99.54.44.72.

[0413] Certificates of analysis are present in Annex 1.

[0414] Two batches are used for the assay. Batch EXP004050B005 is used for experiment day 1, and Batch EXP004050B006 is used for experiment day 5.

[0415] Maintenance medium

[0416] Maintenance Medium: Batch n° : MIL 218C

[0417] Provider: Laboratoire Biopredic International - 8-18 rue Jean Pecker - 35000 Rennes - Frances

TABLE-US-00006 Peptides Tested P1: SEQ ID NO: 283 P2: SEQ ID NO: 246 P3: SEQ ID NO: 284 P4: RPYYSNAPQEIF P5: VLLEQQEQEPQH P6: SEQ ID NO: 245 P7: QQYGIAASPFLQSAA P8: SEQ ID NO: 42

[0418] Compositions tested

[0419] P9 (14-CHL-0723-09) is the Pea composition (SEQ ID Numbers: 50, 85, 74, 140, 82, 136, 189, 77, 169, 149, 171, 178, 143, 127, 190, 141, 147, 133, 186, 125, 122, 119, 87, 90, 86, 89, 138, 129, 123, 120, 117, 113, 110, 121, 105, 98, 55, 161, 19, 317, 135, 130, 146, 177, 160, 170, 188, 83, 78, 36, 96, 159, 26, 330, 168, 148, 184, 151, 151, 165, 114, 284) P10 (14-CHL-0723-010) is the Rice composition (SEQ ID Numbers: 245, 246, 263, 250, 257, 259, 276, 255, 251, 264, 256, 266, 274, 270, 269, 356, 245, 380, 262, 258, 356, 218, 252, 358, 271, 253, 344, 275, 272, 226, 224, 220, 248, 261, 265, 373, 375, 247, 249, 363, 273, 343, 273, 362)

[0420] Application method

[0421] Skin explants were prepared from abdominal plastic surgery. Some explants were delipidated with alcohol to obtain a dehydrated skin.

[0422] These explants were maintained in maintenance medium supplied by the provider Bioprédic

[0423] International for 5 days. Test items are applied twice per day with 5 μL per explant.

[0424] At the end of the test, viabilities controls are realized with the MTT on two explants, the third explant is fixed in the formaldehyde 4% for histology and cell staining.

[0425] For each time of analysis (D1 and D5), histologies on delipidated explants, treated explants with test items, the DMSO 0.3% control and water control, are performed.

[0426] After receipt in the laboratory, each skin explant in the maintenance medium is delipidated with 5 μL alcohol during 3 hours.

[0427] After 3 hours, all skin explants are treated two per day with test items, and they are incubated at 37° C. +/−2° C., 5% CO2 for 1 day or 5 days.

[0428] Integrity of the system is realized at day 1 and day 5 with a viability control with MTT.

[0429] Immunostaining

[0430] Histology is realized by the laboratory Gredeco and the immunostaining to elastin and Ki67 are realized by the same laboratory. Immunostaining to filaggrin is realized by the laboratory

[0431] Intertek.

[0432] The detection of elastin (rabbit monoclonal antibody, clone P15502, LSBio) is performed using an immunoperoxidase technique two layers (ABC kit, Vector Laboratories) and revealed by AEC (3-amino-9 -ethylcarbazole). The immunohistochemical staining intensity in the elastic fibers is evaluated using a semi-quantitative histological score.

[0433] Epithelial proliferation was analyzed by immunohistochemistry using anti-Ki67 antibody. Immunodetection was performed using an indirect immunoperoxidase technique three layers, amplified (DAKO kit) and revealed by AEC (3-Amino-9-ethylcarbazole). Counting the number of labeled cells (keratinocytes of the basal layer of the epidermis) is performed and provides the total number of basal cells to calculate the % of labeled cells.

[0434] The specific staining of filaggrin is performed with an immunoperoxidase staining (ABC kit Fisher). The intensity of immunohistochemical marker in the epidermis is evaluated relative to the negative control of the solvent (Water or DMSO 0.3%).

[0435] C: Results

[0436] Viability control

[0437] The integrity control and the viability control are present in FIG. 1. These controls do allow to validate the assay system. The viability is >50% for test items, and they do not show a cytotoxicity according to the test.

[0438] Immunostaining

[0439] Elastin Expression

[0440] The elastic fibers of the dermis were revealed by staining with the catechin and morphometrically quantified by analysis by computer-assisted image. The percentage area taken up by elastic fibers in the dermis was calculated in the dermis and the average superficial dermis. Results are presented in FIGS. 101, 105, 107, and 108.

TABLE-US-00007 TABLE 3 Morphometric quantification of elastic fibers in the superficial dermis (%) and middle dermis. All samples dissolved in water except where indicated. Morphometric Morphometric quantification of elastic quantification of elastic fibers in the superficial fibers in the middle dermis (%) dermis (%) Conditions D 1 D 5 D 1 D 5 Dehydrated with alcohol and hydrated with 4.31 4.9 5 5.83 water Dehydrated 2.38 7.26 4.39 9.59 EGF (Epidermal Growth Factor) 10 ng/mL 3.64 5.61 5.68 6,.61 Dehydrated with alcohol and hydrated with 3.76 7.24 6 10.36 DMSO 0.3% 0723.01 4.45 10.21 7.59 10.17 0723.02 6.09 7.59 11.,75 9.08 0723.03 3 11.68 4.9 9 0723.04 3.28 8.94 5.22 9 0723.05 6.34 6.26 8.8 6.61 0723.06 (dissolved into DMSO 0.3% 3.8 4.03 4.54 8.67 instead of water) 0723.07 (dissolved into DMSO 0.3% 4 5.15 6.46 5.33 instead of water) 0723.08 2.7 5.32 3.52 7.27 0723.09 3.26 8.26 5.75 7.92 0723.10 4.1 8 5.73 8.34

[0441] Under the experimental conditions of the study, 0723-1 and 0723-3 samples show an increase by twice of elastic fibers in the superficial dermis compared to control water (Figure), and an increase in the middle dermis compared to the water control at D5.

[0442] The 0723-2 sample shows an increase doubled in the middle dermis at day 1 compared to control water and an increase at day 5.

[0443] Ki67 Expression

[0444] The results of the immunohistochemical analysis of Ki67 are reported in

[0445] Table 4 and expressed as % of labelled at the basal layer of the epidermis. The FIG. 115 shows the percentage of Ki 67 cells compared to negative controls (water or DMSO). Immunohistochemical analysis of mitotic activity is shown in annex 4 with a reminder of the average for each analysed conditions.

TABLE-US-00008 TABLE 4 % of Ki67 positive cells in the basal layer of the epidermis. All samples dissolved in water except where indicated. Conditions D 1 D 5 Dehydrated with alcohol and hydrated with 19.09 3.53 water Dehydrated 17.05 1.76 EGF (Epidermal Growth Factor) 10 ng/mL 25.11 4.2 Dehydrated with alcohol and hydrated with 17.2 2.61 DMSO 0.3% 0723.01 18.57 3.92 0723.02 19.61 6.73 0723.03 22.01 10.04 0723.04 14.97 11.36 0723.05 9.48 3.08 0723.06 (dissolved into DMSO 0.3% instead 31.97 5.04 of water) 0723.07 (dissolved into DMSO 0.3% instead 22.22 5.26 of water) 0723.08 27.83 5.72 0723.09 31.02 2.4 0723.10 31.94 3.57

[0446] Under the experimental conditions of the study, test item 0723-06, 0723-08, 0723-09 and 0723-010 show an increase in the number of mitotic cells compared to EGF at day 1. A decrease in the mitotic index was observed on day 5 compared to day 1 for all analysed conditions.

[0447] The decrease in this cell staining on day 5 is caused by the model. Indeed, after approximately 3 days cell turnover is exhausted on this model.

[0448] The invention is not limited to the embodiments hereinbefore described which may be varied in construction and detail without departing from the spirit of the invention.

TABLE-US-00009 SEQUENCES PROTEIN: P13918-2-PEA MAATTMKASFPLLMLMGISFLASVCVSSRSDPQNPFIFKSNKFQTLFENENGHIRLLQKFDQRSKIFENLQNYRLLEYKSKPHTIFLPQHTDADYI LVVLSGKAILTVLKPDDRNSFNLERGDTIKLPAGTIAYLVNRDDNEELRVLDLAIPVNRPGQLQSFLLSGNQNQQNYLSGFSKNILEASFNTDYEE IEKVLLEEHEKETQHRRSLKDKRQQSQEENVIVKLSRGQIEELSKNAKSTSKKSVSSESEPFNLRSRGPIYSNEFGKFFEITPEKNPQLQDLDIFVNS VEIKEGSLLLPHYNSRAIVIVTVNEGKGDFELVGQRNENQQEQRKEDDEEEEQGEEEINKQVQNYKAKLSSGDVFVIPAGHPVAVKASSNLDLL GFGINAENNQRNFLAGDEDNVISQIQRPVKELAFPGSAQEVDRILENQKQSHFADAQPQQRERGSRETRDRLSSV [SEQ ID 1] PEPTIDE: QNYLSGFSKNILE [SEQ ID 15] PEPTIDE: TIKLPAGTIAYLVNRDDNEE [SEQ ID 16] PEPTIDE: LAIPVNRPGQLQSFL [SEQ ID 17] PEPTIDE: AIPVNRPGQLQ [SEQ ID 18] PEPTIDE: PAGHPVAVK [SEQ ID 19] PEPTIDE: VQNYKAKLSSGDVFVIPAG [SEQ ID 20] PEPTIDE: NNQRNFLAGDEDNVISQIQRPVKE [SEQ ID 21] PEPTIDE: INKQVQNYKAKLSSGDVFVIPAG [SEQ ID 22] PEPTIDE: LAIPVNRPGQ [SEQ ID 23] PEPTIDE: NFLAGDEDNVISQIQRPVKE [SEQ ID 24] PEPTIDE: DLAIPVNRPGQLQSF [SEQ ID 25] PEPTIDE: VIPAGHPVAVK [SEQ ID 26] PEPTIDE: DTIKLPAGTIAYLVNRDDNEE [SEQ ID 27] PEPTIDE: LAIPVNRPGQLQSF [SEQ ID 28] PEPTIDE: KQVQNYKAKLSSGDVFVIPAG [SEQ ID 29] PEPTIDE: RGDTIKLPAGTIAYLVNRDDNEE [SEQ ID 30] PEPTIDE: FLAGDEDNVISQIQRPVKE [SEQ ID 31] PEPTIDE: LAIPVNRPGQLQS [SEQ ID 32] PEPTIDE: VLDLAIPVNRPGQLQ [SEQ ID 33] PEPTIDE: DLAIPVNRPGQLQ [SEQ ID 34] PEPTIDE: VFVIPAGHPVAVK [SEQ ID 35] PEPTIDE: TIFLPQHTDADYILVVLSGK [SEQ ID 36] PEPTIDE: NQRNFLAGDEDNVISQIQRPVKE [SEQ ID 37] PEPTIDE: LAIPVNRPGQLQ [SEQ ID 38] PEPTIDE: HPVAVKASSNLDLLGFG [SEQ ID 39] PEPTIDE: LAIPVNRPGQL [SEQ ID 40] PEPTIDE: DLAIPVNRPGQL [SEQ ID 41] PEPTIDE: SKPHTIFLPQHTDADYILVVLSGK [SEQ ID 42] PEPTIDE: FVIPAGHPVAVK [SEQ ID 43] PEPTIDE: DLAIPVNRPGQLQS [SEQ ID 44] PEPTIDE: SGDVFVIPAGHPVAVKASSNLD [SEQ ID 45] PEPTIDE: AIPVNRPGQLQSF [SEQ ID 46] PEPTIDE: ELAFPGSAQEVDR [SEQ ID 47] PEPTIDE: LAIPVNRPGQLQSFLLSG [SEQ ID 48] PEPTIDE: VFVIPAGHPVAVKASSNLDLLGFG [SEQ ID 49] PEPTIDE: AGHPVAVK [SEQ ID 50] PEPTIDE: HPVAVKASSNLDLLGFGINAE [SEQ ID 51] PEPTIDE: LAIPVNRPGQLQSFLLSGNQNQ [SEQ ID 52] PEPTIDE: SGDVFVIPAG [SEQ ID 53] PEPTIDE: GSLLLPHYNSRAIVIVTVNE [SEQ ID 54] PEPTIDE: NFLAGDEDNVISQIQRPVK [SEQ ID 55] PEPTIDE: SGDVFVIPAGHPVA [SEQ ID 56] PEPTIDE: GSLLLPHYNSRAIVIV [SEQ ID 57] PEPTIDE: RGDTIKLPAGTIAYLVNRDD [SEQ ID 58] PEPTIDE: SGDVFVIPAGHPVAVK [SEQ ID 59] PEPTIDE: LSSGDVFVIPAGHPVAVK [SEQ ID 60] PEPTIDE: LDLAIPVNRPGQL [SEQ ID 61] PEPTIDE: AIPVNRPGQL [SEQ ID 62] PEPTIDE: LAIPVNRPGQLQSFLL [SEQ ID 63] PEPTIDE: PHTIFLPQHTDADYILVVLSGK [SEQ ID 64] PEPTIDE: VFVIPAGHPVAVKASSNLD [SEQ ID 65] PEPTIDE: LAIPVNRPGQLQSFLLS [SEQ ID 66] PEPTIDE: VLDLAIPVNRPGQLQSF [SEQ ID 67] PEPTIDE: AIPVNRPGQLQS [SEQ ID 68] PEPTIDE: DTIKLPAGTIAYLVNRDDNE [SEQ ID 69] PEPTIDE: NYKAKLSSGDVFVIPAG [SEQ ID 70] PEPTIDE: GKAILTVLKPDDRNSFNLE [SEQ ID 71] PEPTIDE: YKSKPHTIFLPQHTDAD [SEQ ID 72] PEPTIDE: ASSNLDLLGFG [SEQ ID 73] PEPTIDE: DEEEEQGEEEINK [SEQ ID 74] PEPTIDE: YKSKPHTIFLPQHTD [SEQ ID 75] PEPTIDE: VLDLAIPVNR [SEQ ID 76] PEPTIDE: FFEITPEKNPQLQDLDIFVNSVEIK [SEQ ID 77] PEPTIDE: TIFLPQHTDADYIL [SEQ ID 78] PEPTIDE: SFLLSGNQNQQNYLSG [SEQ ID 79] PEPTIDE: SFLLSGNQNQQNYLSGFS [SEQ ID 80] PEPTIDE: NQQEQRKEDDEEEEQGEEE [SEQ ID 81] PEPTIDE: EEQGEEEINK [SEQ ID 82] PEPTIDE: SRGPIYSNE [SEQ ID 83] PEPTIDE: EDDEEEEQGEEEINK [SEQ ID 84] PEPTIDE: DDEEEEQGEEEINK [SEQ ID 85] PEPTIDE: KEDDEEEEQGEEEIN [SEQ ID 86] PEPTIDE: KEDDEEEEQGEE [SEQ ID 87] PEPTIDE: QRKEDDEEEEQGEEE [SEQ ID 88] PEPTIDE: KEDDEEEEQGEEEINK [SEQ ID 89] PEPTIDE: KEDDEEEEQGEEE [SEQ ID 90] PROTEIN: Q9M3X6-3-PEA MATTIKSRFPLLLLLGIIFLASVVCVTYANYDEGSEPRVPAQRERGRQEGEKEEKRHGEWRPSYEKEEDEEEGQRERGRQEGEKEEKRHGEWR PSYEKQEDEEEKQKYRYQREKEDEEEKQKYQYQREKKEQKEVQPGRERWEREEDEEQVDEEWRGSQRREDPEERARLRHREERTKRDRRHQ REGEEEERSSESQERRNPFLFKSNKFLTLFENENGHIRLLQRFDKRSDLFENLQNYRLVEYRAKPHTIFLPQHIDADLILVVLSGKAILTVLSPNDR NSYNLERGDTIKLPAGTTSYLVNQDDEEDLRLVDLVIPVNGPGKFEAFDLAKNKNQYLRGFSKNILEASYNTRYETIEKVLLEEQEKDRKRRQQG EETDAIVKVSREQIEELKKLAKSSSKKSLPSEFEPINLRSHKPEYSNKFGKLFEITPEKKYPQLQDLDLFVSCVEINEGALMLPHYNSRAIVVLLVNEG KGNLELLGLKNEQQEREDRKERNNEVQRYEARLSPGDVVIIPAGHPVAITASSNLNLLGFGINAENNERNFLSGSDDNVISQIENPVKELTFPGS VQEINRLIKNQKQSHFANAEPEQKEQGSQGKRSPLSSILGTFY [SEQ ID 2] PEPTIDE: HPVAITASSNLNLLG [SEQ ID 91] PEPTIDE: ASSNLNLLGFG [SEQ ID 92] PEPTIDE: ITASSNLNLLGFG [SEQ ID 93] PEPTIDE: ITASSNLNLLGFGINAE [SEQ ID 94] PEPTIDE: SSNLNLLGFG [SEQ ID 95] PEPTIDE: VDLVIPVNGPGKF [SEQ ID 96] PEPTIDE: LVIPVNGPGKFE [SEQ ID 97] PEPTIDE: LVIPVNGPGKFEA [SEQ ID 98] PEPTIDE: LRLVDLVIPVNGPGKFE [SEQ ID 99] PEPTIDE: YRAKPHTIFLPQHIDAD [SEQ ID 100] PEPTIDE: HPVAITASSNLNLLGFGINAE [SEQ ID 101] PEPTIDE: SNLNLLGFG [SEQ ID 102] PEPTIDE: HPVAITASSNLNLLGFGINAENNE [SEQ ID 103] PEPTIDE: LVDLVIPVNGPGKFE [SEQ ID 104] PEPTIDE: LVIPVNGPGKF [SEQ ID 105] PEPTIDE: TIKLPAGTTSYLVNQDDE [SEQ ID 106] PEPTIDE: DLRLVDLVIPVNGPGKFE [SEQ ID 107] PEPTIDE: EDLRLVDLVIPVNGPGKFE [SEQ ID 108] PEPTIDE: HPVAITASSNLNLLGFG [SEQ ID 109] PEPTIDE: LVDLVIPVNGPGKFEAFDLAK [SEQ ID 110] PEPTIDE: DNVISQIENPVKE [SEQ ID 111] PEPTIDE: VVIIPAGHPVAITASSNLNLLGFG [SEQ ID 112] PEPTIDE: LVDLVIPVNGPGKFEAF [SEQ ID 113] PEPTIDE: YPQLQDLDL [SEQ ID 114]] PEPTIDE: VIPVNGPGKF [SEQ ID 115 PEPTIDE: SKKSLPSE [SEQ ID 116] PEPTIDE: LPQHIDADLILVVLSGK [SEQ ID 117] PEPTIDE: RGDTIKLPAGTTSYLVNQD [SEQ ID 118] PEPTIDE: IPVNGPGKF [SEQ ID 119] PEPTIDE: LPQHIDADL [SEQ ID 120] PEPTIDE: LVIPVNGPGK [SEQ ID 121] PEPTIDE: IFLPQHIDAD [SEQ ID 122] PEPTIDE: LPQHIDAD [SEQ ID 123] PEPTIDE: VIPVNGPGK [SEQ ID 124] PEPTIDE: IFLPQHIDA [SEQ ID 125] PEPTIDE: TIKLPAGTTSYLVNQDDEE [SEQ ID 126] PEPTIDE: HGEWRPSYEKEEDEEEGQRER [SEQ ID 127] PEPTIDE: EKRHGEWRPSYEKEEDEEEGQRE [SEQ ID 128] PEPTIDE: LPAGTTSYLVNQDDEEDLR [SEQ ID 129] PEPTIDE: PSYEKEEDEEEGQRER [SEQ ID 130] PEPTIDE: EKRHGEWRPSYE [SEQ ID 131] PEPTIDE: TIKLPAGTTSYLVNQDDEED [SEQ ID 132] PEPTIDE: HGEWRPSYEKQEDEEEK [SEQ ID 133] PEPTIDE: EWRPSYEKEEDEEE [SEQ ID 134] PEPTIDE: PSYEKEEDEEEGQR [SEQ ID 135] PEPTIDE: EKEEDEEEGQR [SEQ ID 136] PEPTIDE: EWRPSYEKEEDEEEGQRE [SEQ ID 137] PEPTIDE: KEEDEEEGQR [SEQ ID 138] PEPTIDE: VQPGRERWEREEDEEQVDE [SEQ ID 139] PEPTIDE: DVVIIPAGHPVA [SEQ ID 140] PEPTIDE: HGEWRPSYEKQEDE [SEQ ID 141] PEPTIDE: EEDEEEGQR [SEQ ID 142] PEPTIDE: HGEWRPSYEKEEDEEEGQR [SEQ ID 143] PEPTIDE: EEWRGSQRREDPEE [SEQ ID 144] PEPTIDE: REEDEEQVDEEWRGSQRREDPEE [SEQ ID 145] PEPTIDE: RHGEWRPSY [SEQ ID 146] PEPTIDE: HGEWRPSYEKQEDEE [SEQ ID 147] PEPTIDE: VVIIPAGHPVA [SEQ ID 148] PEPTIDE: HGEWRPSYE [SEQ ID 149] PEPTIDE: KEEDEEEGQRER [SEQ ID 150] PEPTIDE: VVIIPAGHPVAIT [SEQ ID 151] PEPTIDE: EKRHGEWRPSYEKEEDE [SEQ ID 152] PEPTIDE: QVDEEWRGSQRREDPEE [SEQ ID 153] PEPTIDE: GDTIKLPAGTTSYLVNQDDEEDLR [SEQ ID 154] PEPTIDE: GSEPRVPAQRE [SEQ ID 155] PEPTIDE: EEKRHGEWRPSYEKE [SEQ ID 156] PEPTIDE: EWRPSYEKEEDEE [SEQ ID 157] PEPTIDE: NYDEGSEPRVPAQRE [SEQ ID 158] PEPTIDE: VIIPAGHPVAIT [SEQ ID 159] PEPTIDE: RHGEWRPSYEK [SEQ ID 160] PEPTIDE: NYDEGSEPR [SEQ ID 161] PEPTIDE: WRPSYEKEEDEE [SEQ ID 162] PEPTIDE: WRPSYEKQEDEEE [SEQ ID 163] PEPTIDE: EKRHGEWRPSYEKQEDEEE [SEQ ID 164] PEPTIDE: VVIIPAGHPVAITA [SEQ ID 165] PEPTIDE: KRHGEWRPSYE [SEQ ID 166] PEPTIDE: GSDDNVISQIENPVKE [SEQ ID 167] PEPTIDE: VVIIPAGHPV [SEQ ID 168] PEPTIDE: HGEWRPSY [SEQ ID 169] PEPTIDE: RPSYEKEEDEEEGQR [SEQ ID 170] PEPTIDE: HGEWRPSYEK [SEQ ID 171] PEPTIDE: KRHGEWRPSYEKEE [SEQ ID 172] PEPTIDE: VVIIPAGHPVAITAS [SEQ ID 173] PEPTIDE: RGDTIKLPAGTTSYLVNQDDEED [SEQ ID 174] PEPTIDE: KRHGEWRPSYEKQEDEEE [SEQ ID 175] PEPTIDE: DEEQVDEEWRGSQRREDPEE [SEQ ID 176] PEPTIDE: RHGEWRPSYE [SEQ ID 177] PEPTIDE: HGEWRPSYEKE [SEQ ID 178] PEPTIDE: KRHGEWRPSYEKEEDEEE [SEQ ID 179] PEPTIDE: EKRHGEWRPSYEKEEDEEE [SEQ ID 180] PEPTIDE: TIKLPAGTTSYLVNQDDEEDLRLVD [SEQ ID 181] PEPTIDE: WRPSYEKEEDEEEGQRE [SEQ ID 182] PEPTIDE: KRHGEWRPSYEKEEDEE [SEQ ID 183] PEPTIDE: VVIIPAGHPVAI [SEQ ID 184] PEPTIDE: EWRGSQRREDPEE [SEQ ID 185] PEPTIDE: HGEWRPSYEKQEDEEEKQK [SEQ ID 186] PEPTIDE: SGSDDNVISQIENPVKE [SEQ ID 187] PEPTIDE: RPSYEKEEDEEEGQRER [SEQ ID 188] PEPTIDE: EKEEDEEEGQRER [SEQ ID 189] PEPTIDE: HGEWRPSYEKQ [SEQ ID 190] PEPTIDE: WRPSYEKEEDEEE [SEQ ID 191] PEPTIDE: LAKNKNQYLRGFS [SEQ ID 192] PEPTIDE: NKNQYLRGFS [SEQ ID 193] PEPTIDE: LRGFSKNILE [SEQ ID 194] PEPTIDE: LAKNKNQYLRGFSKN [SEQ ID 195] PEPTIDE: TVLSPNDRNSY [SEQ ID 196] PEPTIDE: QYLRGFSKNILE [SEQ ID 197] PEPTIDE: GKAILTVLSPNDRNSYNLE [SEQ ID 198] PEPTIDE: RGFSKNILE [SEQ ID 199] PEPTIDE: NKNQYLRGFSKNILE [SEQ ID 200] PEPTIDE: ASSNLNLLGFGINAE [SEQ ID 201] PEPTIDE: ASSNLNLLGF [SEQ ID 202] PEPTIDE: LAKNKNQYLRGFSK [SEQ ID 203] PEPTIDE: RGDTIKLPAGTTSYLVNQDDEE [SEQ ID 204] PEPTIDE: ARLSPGDVVIIPAGHPVAITASSN [SEQ ID 205] PEPTIDE: VQRYEARLSPGD [SEQ ID 206] PEPTIDE: ARLSPGDVVIIPAGHPVAIT [SEQ ID 207] PEPTIDE: RGDTIKLPAGTTSYLVNQDDE [SEQ ID 208] PEPTIDE: ARLSPGDVVIIPAGHPVA [SEQ ID 209] PEPTIDE: GALMLPHYNSRAIVVLLVNE [SEQ ID 210] PEPTIDE: ARLSPGDVVIIPAGHPVAITASS [SEQ ID 211] PEPTIDE: LSPGDVVIIPAGHPVAITASSNLNLLGFGINAENNER [SEQ ID 212] PEPTIDE: ARLSPGDVVIIPAGHPVAITAS [SEQ ID 213] PEPTIDE: LSPGDVVIIPAGHPVAITASSNL [SEQ ID 214] PEPTIDE: ARLSPGDVVIIPAGHPVAITA [SEQ ID 215] PROTEIN: Q0DEV5-5-RICE MSALTTSQLATSATGFGIADRSAPSSLLRHGFQGLKPRSPAGGDATSLSVTTSARATPKQQRSVQRGSRRFPSVVVYATGAGMNVVFVGAEM APWSKTGGLGDVLGGLPPAMAANGHRVMVISPRYDQYKDAWDTSVVAEIKVADRYERVRFFHCYKRGVDRVFIDHPSFLEKVWGKTGEKIY GPDTGVDYKDNQMRFSLLCQAALEAPRILNLNNNPYFKGTYGEDVVFVCNDWHTGPLASYLKNNYQPNGIYRNAKVAFCIHNISYQGRFAFE DYPELNLSERFRSSFDFIDGYDTPVEGRKINWMKAGILEADRVLTVSPYYAEELISGIARGCELDNIMRLTGITGIVNGMDVSEWDPSKDKYITA KYDATTAIEAKALNKEALQAEAGLPVDRKIPLIAFIGRLEEQKGPDVMAAAIPELMQEDVQIVLLGTGKKKFEKLLKSMEEKYPGKVRAVVKFNA PLAHLIMAGADVLAVPSRFEPCGLIQLQGMRYGTPCACASTGGLVDTVIEGKTGFHMGRLSVDCKVVEPSDVKKVAATLKRAIKVVGTPAYEE MVRNCMNQDLSWKGPAKNWENVLLGLGVAGSAPGIEGDEIAPLAKENVAAP [SEQ ID 3] PEPTIDE: NWENVLLGLGVAGSAPGIEGDEIAPLAK [SEQ ID 216] PEPTIDE: YDQYKDAWDTSVVAEIK [SEQ ID 217] PEPTIDE: SSFDFIDGYDTPVEGR [SEQ ID 218] PEPTIDE: GPDTGVDYKDNQM [SEQ ID 219] PEPTIDE: ILNLNNNPYFK [SEQ ID 220] PEPTIDE: VVGTPAYEE [SEQ ID 221] PEPTIDE: IDGYDTPVEGR [SEQ ID 222] PEPTIDE: VVGTPAYE [SEQ ID 223] PEPTIDE: IYGPDTGVDYK [SEQ ID 224] PEPTIDE: VAGSAPGIEGDE [SEQ ID 225] PEPTIDE: IYGPDTGVDYKDNQMR [SEQ ID 226] PEPTIDE: VVGTPAYEEMVR [SEQ ID 227] PEPTIDE: DFIDGYDTPVEGR [SEQ ID 228] PEPTIDE: LGLGVAGSAPGIEGDEIAPLAK [SEQ ID 229] PEPTIDE: FNAPLAHLIMAGADVLAVPSR [SEQ ID 230] PEPTIDE: LGLGVAGSAPGIEGDE [SEQ ID 231] PEPTIDE: LGLGVAGSAPGIEGDEIAPL [SEQ ID 232] PEPTIDE: VLTVSPYYAEELISGIAR [SEQ ID 233] PEPTIDE: EALQAEAGLPVDR [SEQ ID 234] PEPTIDE: LGLGVAGSAPGIEGD [SEQ ID 235] PEPTIDE: IMAGADVLAVPSR [SEQ ID 236] PEPTIDE: GLGVAGSAPGIEGDE [SEQ ID 237] PEPTIDE: EALQAEAGLPVDRK [SEQ ID 238] PEPTIDE: TGGLGDVLGGLPPAMAANGHR [SEQ ID 239] PEPTIDE: LEEQKGPDVMA [SEQ ID 240] PEPTIDE: LGVAGSAPGIEGDEIAPLAK [SEQ ID 241] PEPTIDE: GLGVAGSAPGIEGDEIAPLAK [SEQ ID 242] PEPTIDE: TGGLGDVLGGLPPAM [SEQ ID 243] PEPTIDE: NVLLGLGVAGSAPGIEGDE [SEQ ID 244] PROTEIN: P14323-6-RICE MASSVFSRFSIYFCVLLLCHGSMAQLFNPSTNPWHSPRQGSFRECRFDRLQAFEPLRKVRSEAGVTEYFDEKNELFQCTGTFVIRRVIQPQGLL VPRYTNIPGVVYIIQGRGSMGLTFPGCPATYQQQFQQFSSQGQSQSQKFRDEHQKIHQFRQGDIVALPAGVAHWFYNDGDAPIVAVYVYDV NNNANQLEPRQKEFLLAGNNNRAQQQQVYGSSIEQHSGQNIFSGFGVEMLSEALGINAVAAKRLQSQNDQRGEIIHVKNGLQLLKPTLTQQ QEQAQAQDQYQQVQYSERQQTSSRWNGLEENFCTIKVRVNIENPSRADSYNPRAGRITSVNSQKFPILNLIQMSATRVNLYQNAILSPFWNV NAHSLVYMIQGRSRVQVVSNFGKTVFDGVLRPGQLLIIPQHYAVLKKAEREGCQYIAIKTNANAFVSHLAGKNSVFRALPVDVVANAYRISRE QARSLKNNRGEEHGAFTPRFQQQYYPGLSNESESETSE [SEQ ID 4] PEPTIDE: TVFDGVLRPGQL [SEQ ID 245] PEPTIDE: RLQSQNDQRGEIIHVK [SEQ ID 246] PROTEIN: P29835-5-RICE MASKVVFFAAALMAAMVAISGAQLSESEMRFRDRQCQREVQDSPLDACRQVLDRQLTGRERFQPMFRRPGALGLRMQCCQQLQDVSRE CRCAAIRRMVRSYEESMPMPLEQGWSSSSSEYYGGEGSSSEQGYYGEGSSEEGYYGEQQQQPGMTRVRLTRARQYAAQLPSMCRVEPQQC SIFAAGQY [SEQ ID 5] PEPTIDE: EGYYGEQQQQPGMTR [SEQ ID 247] PEPTIDE: GYYGEQQQQPGMTR [SEQ ID 248] PEPTIDE: EEGYYGEQQQQPGMTR [SEQ ID 249] PEPTIDE: YYGGEGSSSEQGYYGEGSSE [SEQ ID 250] PEPTIDE: YGGEGSSSEQGYYGEGSSE [SEQ ID 251] PEPTIDE: SSEEGYYGEQQQQPGMTR [SEQ ID 252] PEPTIDE: SEEGYYGEQQQQPGMTR [SEQ ID 253] PEPTIDE: QGYYGEGSSEE [SEQ ID 254] PEPTIDE: YGGEGSSSEQGYYGEGSSEEGY [SEQ ID 255] PEPTIDE: YGEQQQQPGMTR [SEQ ID 256] PEPTIDE: YYGEQQQQPGMTR [SEQ ID 257] PEPTIDE: SYEESMPMPLEQGWSSSSSE [SEQ ID 258] PEPTIDE: YYGEGSSEEGYYGEQQQQPGMTR [SEQ ID 259] PEPTIDE: QQQQPGMTRV [SEQ ID 260] PEPTIDE: GEQQQQPGMTR [SEQ ID 261] PEPTIDE: SYEESMPMPLEQGWSSSSSEY [SEQ ID 262] PEPTIDE: YYGGEGSSSEQGYYGEGSSEEGY [SEQ ID 263] PEPTIDE: YGEQQQQPGMTRVR [SEQ ID 264] PEPTIDE: GEGSSEEGYYGEQQQQPGMTR [SEQ ID 265] PEPTIDE: YGEGSSEEGYYGEQQQQPGMTR [SEQ ID 266] PEPTIDE: QQQQPGMTRVR [SEQ ID 267] PEPTIDE: QYAAQLPSMCRVEPQQCSIFAAGQY [SEQ ID 268] PROTEIN: P0C1U8-5-Staphylococcus aureus MKGKFLKVSSLFVATLTTATLVSSPAANALSSKAMDNHPQQTQSSKQQTPKIQKGGNLKPLEQREHANVILPNNDRHQITDTTNGHYAPVTYI QVEAPTGTFIASGVVVGKDTLLTNKHVVDATHGDPHALKAFPSAINQDNYPNGGFTAEQITKYSGEGDLAIVKFSPNEQNKHIGEVVKPATMS NNAETQVNQNITVTGYPGDKPVATMWESKGKITYLKGEAMQYDLSTTGGNSGSPVFNEKNEVIGIHWGGVPNEFNGAVFINENVRNFLKQ NIEDIHFANDDQPNNPDNPDNPNNPDNPNNPDEPNNPDNPNNPDNPDNGDNNNSDNPDAA [SEQ ID 14] PEPTIDE: APTGTFIASGVVVGKD [SEQ ID 413] PEPTIDE: LAIVKFSPNEQNKHIGE [SEQ ID 414] PEPTIDE: RHQITDTTNGHYAPVTYIQVE [SEQ ID 415] PEPTIDE: GDLAIVKFSPNEQNKHIGE [SEQ ID 416] PEPTIDE: NPDNPDNPNNPDNPNNPD [SEQ ID 417] PROTEIN: P14614-4-RICE MATIAFSRLSIYFCVLLLCHGSMAQLFGPNVNPWHNPRQGGFRECRFDRLQAFEPLRRVRSEAGVTEYFDEKNEQFQCTGTFVIRRVIEPQGL LVPRYSNTPGMVYIIQGRGSMGLTFPGCPATYQQQFQQFLPEGQSQSQKFRDEHQKIHQFRQGDIVALPAGVAHWFYNEGDAPVVALYVF DLNNNANQLEPRQKEFLLAGNNNREQQMYGRSIEQHSGQNIFSGFNNELLSEALGVNALVAKRLQGQNDQRGEIIRVKNGLKLLRPAFAQQ QEQAQQQEQAQAQYQVQYSEEQQPSTRCNGLDENFCTIKARLNIENPSHADTYNPRAGRITRLNSQKFPILNLVQLSATRVNLYQNAILSPF WNVNAHSLVYIVQGHARVQVVSNLGKTVFNGVLRPGQLLIIPQHYVVLKKAEHEGCQYISFKTNANSMVSHLAGKNSIFRAMPVDVIANAYR ISREQARSLKNNRGEELGAFTPRYQQQTYPGFSNESENEALE [SEQ ID 6] PEPTIDE: TVFNGVLRPGQL [SEQ ID 269] PEPTIDE: TVFNGVLRPGQLL [SEQ ID 270] PEPTIDE: SGFNNELLSEALGVNALVAK [SEQ ID 271] PEPTIDE: NGVLRPGQL [SEQ ID 272] PEPTIDE: ALVAKRLQGQN DQRG El [SEQ ID 273] PEPTIDE: VPRYSNTPGM [SEQ ID 274] PEPTIDE: PRYSNTPGMV [SEQ ID 275] PEPTIDE: YSNTPGMVY [SEQ ID 276] PEPTIDE: LVPRYSNTPGM [SEQ ID 277] PEPTIDE: FYNEGDAPVV [SEQ ID 278] PEPTIDE: FYNEGDAPVVAL [SEQ ID 279] PEPTIDE: FEPLRRVRSEAGVTE [SEQ ID 280] PEPTIDE: FYNEGDAPVVALY [SEQ ID 281] PEPTIDE: FYNEGDAPVVA [SEQ ID 282] PROTEIN: P09918-14-Pisum sativum MFSGVTGILNRGHKIKGTVVLMRKNVLDINSLTTVGGVIGQGFDILGSTVDNLTAFLGRSVSLQLISATKPDATGKGKLGKATFLEGIISSLPTLG AGQSAFKIHFEWDDDMGIPGAFYIKNFMQTEFFLVSLTLDDIPNHGSIYFVCNSWIYNAKHHKIDRIFFANQTYLPSETPAPLVHYREEELNNLR GDGTGERKEWERIYDYDVYNDLGNPDSGENHARPVLGGSETYPYPRRGRTGRKPTRKDPNSESRSDYVYLPRDEAFGHLKSSDFLTYGLKAVS QNVVPALESVFFDLNFTPNEFDSFDEVHGLYEGGIKLPTNILSQISPLPVLKEIFRTDGENTLKYPPPKVIQVSRSGWMTDEEFAREMLAGVNPN VICCLQEFPPRSKLDSQIYGDHTSKISKEHLEPNLEGLTVEEAIQNKKLFLLDHHDSIMPYLRRINSTSTKAYATRTILFLNNNQNLKPLAIELSLPHP QGDEHGAVSYVYQPALEGVESSIWLLAKAYVIVNDSCYHQLVSHWLNTHAVVEPFVIATNRHLSCLHPIYKLLYPHYRDTMNINSLARLSLVND GGIIEKTFLWGRYSMEMSSKVYKNWVFTEQALPADLIKRGMAIEDPSSPCGVKLVVEDYPYAVDGLEIWAIIKTWVQDYVSLYYTSDEKLRQD SELQAWWKELVEVGHGDKKNEPWWPKMQTREDLIEVCSIVIWTASALHAAVNFGQYSYGGLILNRPTLSRRFMPEKGSAEFEELVKSPQKA YLKTITPKFQTLIDLSVIEILSRHASDELYLGERDNPNWTSDKRALEAFKKFGNKLAEIEKKLTQRNNDEKLRNRHGPVEMPYTLLYPSSKEGLTFR GIPNSISI [SEQ ID 7] PEPTIDE: HGPVEMPYTLLYPSSK [SEQ ID 283] PROTEIN: P02857-1-PEA MAKLLALSLSFCFLLLGGCFALREQPQQNECQLERLDALEPDNRIESEGGLIETWNPNNKQFRCAGVALSRATLQRNALRRPYYSNAPQEIFIQ QGNGYFGMVFPGCPETFEEPQESEQGEGRRYRDRHQKVNRFREGDIIAVPTGIVFWMYNDQDTPVIAVSLTDIRSSNNQLDQMPRRFYLAG NHEQEFLQYQHQQGGKQEQENEGNNIFSGFKRDYLEDAFNVNRHIVDRLQGRNEDEEKGAIVKVKGGLSIISPPEKQARHQRGSRQEEDED EEKQPRHQRGSRQEEEEDEDEERQPRHQRRRGEEEEEDKKERGGSQKGKSRRQGDNGLEETVCTAKLRLNIGPSSSPDIYNPEAGRIKTVTSL DLPVLRWLKLSAEHGSLHKNAMFVPHYNLNANSIIYALKGRARLQVVNCNGNTVFDGELEAGRALTVPQNYAVAAKSLSDRFSYVAFKTNDR AGIARLAGTSSVINNLPLDVVAATFNLQRNEARQLKSNNPFKFLVPARESENRASA [SEQ ID 8] PEPTIDE: LDALEPDNR [SEQ ID 284] PEPTIDE: DALEPDNR [SEQ ID 285] PEPTIDE: HGSLHKNAMFVPHYNLNANSIIYA [SEQ ID 286] PEPTIDE: LAGTSSVINNLPLDVVAATF [SEQ ID 287] PEPTIDE: FREGDIIAVPTGIVFW [SEQ ID 288] PEPTIDE: GTSSVINNLPLDVVAATFNLQRNE [SEQ ID 289] PEPTIDE: KGAIVKVKGGLSIISPPE [SEQ ID 290] PEPTIDE: RLAGTSSVINNLPLD [SEQ ID 291] PEPTIDE: AGTSSVINNLPLDVVAATFNLQRNE [SEQ ID 292] PEPTIDE: AGTSSVINNLPL [SEQ ID 293] PEPTIDE: LAGTSSVINNLPLDVVA [SEQ ID 294] PEPTIDE: AGTSSVINNLPLDV [SEQ ID 295] PEPTIDE: AGRIKTVTSLDLPVLRW [SEQ ID 296] PEPTIDE: AGRIKTVTSLDLPVLR [SEQ ID 297] PEPTIDE: FREGDIIAVPTGIVF [SEQ ID 298] PEPTIDE: AGTSSVINNLPLD [SEQ ID 299] PEPTIDE: LAGTSSVINNLPL [SEQ ID 300] PEPTIDE: LAGTSSVINNLPLDVV [SEQ ID 301] PEPTIDE: EGDIIAVPTGIVF [SEQ ID 302] PEPTIDE: LAGTSSVINNLPLDV [SEQ ID 303] PEPTIDE: AGRALTVPQNYAVAAKSLSD [SEQ ID 304] PEPTIDE: AGRALTVPQNYA [SEQ ID 305] PEPTIDE: LAGTSSVINNLPLD [SEQ ID 306] PEPTIDE: RAGIARLAGTSSVINNLPLDVVA [SEQ ID 307] PROTEIN: P02855-4-PEA DNAEIEKILLEEHEKETHHRRGLRDKRQQSQEKNVIVKVSKKQIEELSKNAKSSSKKSVSSRSEPFNLKSSDPIYSNQYGKFFEITPKKNPQLQDLD IFVNYVEIKEGSLWLPHYNSRAIVIVTVNEGKGDFELVGQRNENQQGLREEDDEEEEQREEETKNQVQSYKAKLTPGDVFVIPAGHPVAVRAS SNLNLLGFGINAENNQRNFLAGEEDNVISQIQKQVKDLTFPGSAQEVDRLLENQKQSYFANAQPQQRETRSQEIKEHLYSILGAF [SEQ ID 9] PEPTIDE: RASSNLNLLGFGINAE [SEQ ID 308] PEPTIDE: VTVNEGKGDFEL [SEQ ID 309] PEPTIDE: VRASSNLNLLGFGINAE [SEQ ID 310] PEPTIDE: VRASSNLNLLGFG [SEQ ID 311] PEPTIDE: HPVAVRASSNLNLLGFG [SEQ ID 312] PEPTIDE: TKNQVQSYKAKLTPGD [SEQ ID 313] PEPTIDE: HPVAVRASSNLNLLG [SEQ ID 314] PEPTIDE: KAKLTPGDVFVIPAG [SEQ ID 315] PEPTIDE: DLTFPGSAQEVDRLLENQK [SEQ ID 316] PEPTIDE: PAGHPVAVR [SEQ ID 317] PEPTIDE: AKLTPGDVFVIPAGHPVA [SEQ ID 318] PEPTIDE: SYKAKLTPGDVFVIPAGHPVA [SEQ ID 319] PEPTIDE: LTPGDVFVIPAGHPVAVR [SEQ ID 320] PEPTIDE: VQSYKAKLTPGDVFVIPAG [SEQ ID 321] PEPTIDE: YKAKLTPGDVFVIPAGHPVA [SEQ ID 322] PEPTIDE: FVIPAGHPVAVR [SEQ ID 323] PEPTIDE: YKAKLTPGDVFVIPAG [SEQ ID 324] PEPTIDE: DLTFPGSAQEVDR [SEQ ID 325] PEPTIDE: AKLTPGDVFVIPAGHPVAVR [SEQ ID 326] PEPTIDE: LTPGDVFVIPAG [SEQ ID 327] PEPTIDE: SYKAKLTPGDVFVIPAG [SEQ ID 328] PEPTIDE: SYKAKLTPGDVFVIPAGHPVAVR [SEQ ID 329] PEPTIDE: VIPAGHPVAVR [SEQ ID 330] PEPTIDE: QVQSYKAKLTPGDVFVIPAG [SEQ ID 331] PEPTIDE: AKLTPGDVFVIPAG [SEQ ID 332] PEPTIDE: HPVAVRASSNLNLLGFGINAE [SEQ ID 333] PEPTIDE: YKAKLTPGDVFVIPAGHPVAVR [SEQ ID 334] PEPTIDE: TKNQVQSYKAKLTPGDVFVIPAG [SEQ ID 335] PEPTIDE: PFNLKSSDPIYS [SEQ ID 336] PEPTIDE: IEKILLEE [SEQ ID 337] PEPTIDE: SRSEPFNLKSSDPIYS [SEQ ID 338] PEPTIDE: HPVAVRASSNLNL [SEQ ID 339] PROTEIN: D3VNE1-5-PEA MAATPIKPLMLLAIAFLASVCVSSRSDQENPFIFKSNRFQTLYENENGHIRLLQKFDKRSKIFENLQNYRLLEYKSKPRTLFLPQYTDADFILVVLSG KATLTVLKSNDRNSFNLERGDTIKLPAGTIAYLANRDDNEDLRVLDLTIPVNKPGQLQSFLLSGTQNQPSLLSGFSKNILEAAFNTNYEEIEKVLLE QQEQEPQHRRSLKDRRQEINEENVIVKVSREQIEELSKNAKSSSKKSVSSESGPFNLRSRNPIYSNKFGKFFEITPEKNQQLQDLDIFVNSVDIKE GSLLLPNYNSRAIVIVTVTEGKGDFELVGQRNENQGKENDKEEEQEEETSKQVQLYRAKLSPGDVFVIPAGHPVAINASSDLNLIGFGINAENN ERNFLAGEEDNVISQVERPVKELAFPGSSHEVDRLLKNQKQSYFANAQPLQRE [SEQ ID 10] PEPTIDE: TLFLPQYTDADFILVVLSGK [SEQ ID 340] PROTEIN: P07728-1-RICE MASINRPIVFFTVCLFLLCNGSLAQQLLGQSTSQWQSSRRGSPRECRFDRLQAFEPIRSVRSQAGTTEFFDVSNEQFQCTGVSVVRRVIEPRGL LLPHYTNGASLVYIIQGRGITGPTFPGCPESYQQQFQQSGQAQLTESQSQSQKFKDEHQKIHRFRQGDVIALPAGVAHWCYNDGEVPVVAIY VTDLNNGANQLDPRQRDFLLAGNKRNPQAYRREVEERSQNIFSGFSTELLSEALGVSSQVARQLQCQNDQRGEIVRVEHGLSLLQPYASLQE QEQGQVQSRERYQEGQYQQSQYGSGCSNGLDETFCTLRVRQNIDNPNRADTYNPRAGRVTNLNTQNFPILSLVQMSAVKVNLYQNALLSPF WNINAHSVVYITQGRARVQVVNNNGKTVFNGELRRGQLLIIPQHYAVVKKAQREGCAYIAFKTNPNSMVSHIAGKSSIFRALPNDVLANAYRI SREEAQRLKHNRGDEFGAFTPIQYKSYQDVYNAAESS [SEQ ID 11] PEPTIDE: EVEERSQNIF [SEQ ID 341] PEPTIDE: VEERSQNIFSGF [SEQ ID 342] PEPTIDE: ASLQEQEQGQVQ [SEQ ID 343] PEPTIDE: QEQEQGQVQSR [SEQ ID 344] PEPTIDE: ASLQEQEQGQVQSR [SEQ ID 345] PEPTIDE: EVEERSQNIFSGF [SEQ ID 346] PEPTIDE: VTDLNNGANQLDPRQRD [SEQ ID 347] PEPTIDE: VEHGLSLLQPYASL [SEQ ID 348] PEPTIDE: IYVTDLNNGANQLDPRQRDFL [SEQ ID 349] PEPTIDE: VTDLNNGANQLDPRQRDFL [SEQ ID 350] PEPTIDE: VEHGLSLLQPYASLQEQEQGQVQSR [SEQ ID 351] PEPTIDE: VTDLNNGANQLDPR [SEQ ID 352] PEPTIDE: IYVTDLNNGANQLDPRQRD [SEQ ID 353] PEPTIDE: YVTDLNNGANQLDPRQRDFL [SEQ ID 354] PEPTIDE: YVTDLNNGANQLDPR [SEQ ID 355] PEPTIDE: STELLSEALGVSSQVAR [SEQ ID 356] PEPTIDE: HGLSLLQPYASLQEQE [SEQ ID 357] PEPTIDE: SGFSTELLSEALGVSSQVAR [SEQ ID 358] PROTEIN: P07730-2-RICE MASINRPIVFFTVCLFLLCDGSLAQQLLGQSTSQWQSSRRGSPRGCRFDRLQAFEPIRSVRSQAGTTEFFDVSNELFQCTGVSVVRRVIEPRGLL LPHYTNGASLVYIIQGRGITGPTFPGCPETYQQQFQQSGQAQLTESQSQSHKFKDEHQKIHRFRQGDVIALPAGVAHWCYNDGEVPVVAIYV TDINNGANQLDPRQRDFLLAGNKRNPQAYRREVEEWSQNIFSGFSTELLSEAFGISNQVARQLQCQNDQRGEIVRVERGLSLLQPYASLQEQ EQGQMQSREHYQEGGYQQSQYGSGCPNGLDETFCTMRVRQNIDNPNRADTYNPRAGRVTNLNSQNFPILNLVQMSAVKVNLYQNALLSP FWNINAHSIVYITQGRAQVQVVNNNGKTVFNGELRRGQLLIVPQHYVVVKKAQREGCAYIAFKTNPNSMVSHIAGKSSIFRALPTDVLANAYR ISREEAQRLKHNRGDEFGAFTPLQYKSYQDVYNVAESS [SEQ ID 12] PEPTIDE: GAFTPLQYKSYQD [SEQ ID 359] PEPTIDE: GLLLPHYTNGASLVY [SEQ ID 360] PEPTIDE: FLLAGNKRNPQAYRRE [SEQ ID 361] PEPTIDE: ALPTDVLANAYR [SEQ ID 362] PEPTIDE: DFLLAGNK [SEQ ID 363] PEPTIDE: DVLANAYR [SEQ ID 364] PEPTIDE: GAFTPLQYK [SEQ ID 365] PEPTIDE: QGDVIALPAGVAHW [SEQ ID 366] PEPTIDE: FGAFTPLQYKSY [SEQ ID 367] PEPTIDE: FLLAGNKRNPQAYR [SEQ ID 368] PEPTIDE: FGAFTPLQYKSYQ [SEQ ID 369] PEPTIDE: GLSLLQPYASLQEQE [SEQ ID 370] PEPTIDE: AFTPLQYK [SEQ ID 371] PEPTIDE: FGAFTPLQYKSYQD [SEQ ID 372] PEPTIDE: GDEFGAFTPLQYK [SEQ ID 373] PEPTIDE: FGAFTPLQYKSYQDV [SEQ ID 374] PEPTIDE: FGAFTPLQYK [SEQ ID 375] PEPTIDE: FGAFTPLQYKS [SEQ ID 376] PEPTIDE: VYIIQGRGITGPTF [SEQ ID 377] PEPTIDE: YIIQGRGITGPTF [SEQ ID 378] PEPTIDE: KTNPNSMVSHIAGK [SEQ ID 379] PEPTIDE: TNPNSMVSHIAGK [SEQ ID 380] PEPTIDE: PNSMVSHIAGKS [SEQ ID 381] PEPTIDE: NIDNPNRADTYNPRAGRVTN [SEQ ID 382] PEPTIDE: QRDFLLAGNKR [SEQ ID 383] PEPTIDE: LLQPYASLQEQE [SEQ ID 384] PEPTIDE: QRDFLLAGNK [SEQ ID 385] PEPTIDE: QEQEQGQMQSR [SEQ ID 386] PEPTIDE: SLLQPYASLQEQE [SEQ ID 387] PEPTIDE: ASLQEQEQGQM [SEQ ID 388] PEPTIDE: ASLQEQEQGQMQSR [SEQ ID 389] PEPTIDE: DFLLAGNKR [SEQ ID 390] PEPTIDE: QAFEPIRSVRSQAGTTEF [SEQ ID 391] PEPTIDE: KTNPNSMVSHIAGKSSIF [SEQ ID 392] PEPTIDE: VRRVIEPRGLLLPHYTNGASL [SEQ ID 393] PEPTIDE: FGAFTPLQYKSYQDVYN [SEQ ID 394] PEPTIDE: IALPAGVAHW [SEQ ID 395] PEPTIDE: RVRQNIDNPNRADTYNPRAGRVTNL [SEQ ID 396] PEPTIDE: NIDNPNRADTYNPRAGRVTNL [SEQ ID 397] PEPTIDE: GAFTPLQYKSYQDVYN [SEQ ID 398] PEPTIDE: PNSMVSHIAGKSSIFR [SEQ ID 399] PEPTIDE: RLQAFEPIRSVRSQAGTTE [SEQ ID 400] PEPTIDE: TNPNSMVSHIAGKSSIFR [SEQ ID 401] PROTEIN: Q0D7S0-3-RICE MASNKVVFSVLLLAVVSVLAATATMAEYHHQDQVVYTPGPLCQPGMGYPMYPLPRCRALVKRQCVGRGTAAAAEQVRRDCCRQLAAVDD SWCRCEAISHMLGGIYRELGAPDVGHPMSEVFRGCRRGDLERAAASLPAFCNVDIPNGGGGVCYWLARSGY [SEQ ID 13] PEPTIDE: ELGAPDVGHPM [SEQ ID 402] PEPTIDE: LGAPDVGHPM [SEQ ID 403] PEPTIDE: ELGAPDVGHPMSEVF [SEQ ID 404] PEPTIDE: ELGAPDVGHPMS [SEQ ID 405] PEPTIDE: ELGAPDVGHPMSEVFR [SEQ ID 406] PEPTIDE: ELGAPDVGHPMSEV [SEQ ID 407] PEPTIDE: ELGAPDVGHPMSE [SEQ ID 408] PEPTIDE: LGAPDVGHPMSE [SEQ ID 409] PEPTIDE: YRELGAPDVGHPMSE [SEQ ID 410] PEPTIDE: LGAPDVGHPMSEV [SEQ ID 411] PEPTIDE: RELGAPDVGHPMSE [SEQ ID 412] ADDITIONAL PEPTIDES (AND SOURCE PROTEIN) HPRPPKPDAPR [SEQ ID 452]-Q0D9DO LQQAPPPPQR [SEQ ID 453]-Q6AVS5 VGWGEQPWSPY [SEQ ID 454]-Q8H920 FHMPP [SEQ ID 455]-O49927 FRRP [SEQ ID 456]-P29835 FWM [SEQ ID 457]-P15838 HMPPS [SEQ ID 458]-049927 PVEMPTLLYPS [SEQ ID 459 HMPSS [SEQ ID 460]-O49927 HRFR [SEQ ID 461]-Q712V4 HRRS [SEQ ID 462]-P13918 HSPR [SEQ ID 463]-P14323 HWF [SEQ ID 464-P14323 MFRR [SEQ ID 465]-Q41000 MFRRP [SEQ ID 466-P29835 MPPS [SEQ ID 467]-049927 MPRR [SEQ ID 468]-P15838 NMPS [SEQ ID 469]-P20698 PHMP [SEQ ID 470]-O49927 PHMPS [SEQ ID 471-O49927 PRRF [SEQ ID 472]-P15838 WMK [SEQ ID 473]-O04434 DSINALEPDHR [SEQ ID 474]-P05692 ELTFPGSVQ [SEQ ID 475]-Q9M3X6 ELTFPGSVQE [SEQ ID 476]-Q9M3X6 IFEDAITIPGR [SEQ ID 477]-P09886 LDALEPDNRIESE [SEQ ID 478]-P02857 KTLDYWPSLR [SEQ ID 479]-P08688 RHGEWGPSY [SEQ ID 480 ILVDGSHDIER [SEQ ID 481]-Q5N725 LVSHPIAAHEGR [SEQ ID 482]-P14614 NLAQAPAQALL [SEQ ID 483]-Q0DJ38 FLPQHTD [SEQ ID 484]-P13918 LEPDNR [SEQ ID 485]-P15838 LQSQND [SEQ ID 486]-P14323 LQSQNDQRGEI [SEQ ID 487]-P14323 QSQNDQRGEIIHVK [SEQ ID 488]-P14323 RGEIIHVK [SEQ ID 489]-P14323 RLQSQNDQ [SEQ ID 490]-P14323 RLQSQNDQRG [SEQ ID 491]-P14323 RLQSQNDQRGEIIH [SEQ ID 492]-P14323 VFDGVLRPG [SEQ ID 493]-P14323 HNPR [SEQ ID 494]-P14614 HPMS [SEQ ID 495]-Q0D7S0 HPSF [SEQ ID 496]-Q0DEV5 MPMP [SEQ ID 497]-P29835 PMPL [SEQ ID 498]-P29835 PNSM [SEQ ID 499]-P07728 WDP [SEQ ID 500]-B5A8N6 LRGFSK [SEQ ID 501]-Q9M3X6 RSQNIF [SEQ ID 502]-P07728 YLRGFS [SEQ ID 503]-Q9M3X6 GALMLPHYN [SEQ ID 504]-Q9M3X6 GALMLPHYNSR [SEQ ID 505]-Q9M3X6 KNPQLQDLDIFVNYVEIK [SEQ ID 700]P02855 PGQLQSFLLSGNQNQQNYLSGFSK [SEQ ID 701]P13918 RGPQQYAEWQINEK [SEQ ID 702]Q6K7K6 VLDLAIPVNRPGQL [SEQ ID 703]Q6K508 GYVGLTFPGCPATHQQQFQLFEQR [SEQ ID 704]P09918 LDVTPLSLGL [SEQ ID 717] EEGIQLVAEAIR [SEQ ID 718] YSLKPLVPR [SEQ ID 719] WHT [SEQ ID 720] WHN [SEQ ID 721] NNPF [SEQ ID 722] MRFR [SEQ ID 723] MPPSS [SEQ ID 724] HMPS [SEQ ID 725] HMPPS [SEQ ID 726] GHPM [SEQ ID 727] FWN [SEQ ID 728] FHMP [SEQ ID 729] WTIVQGLPIDE [SEQ ID 730] GYPMYPLPR [SEQ ID 731] HGGEGGRPY [SEQ ID 732] LRGFSK [SEQ ID 733] GALMLPHYN [SEQ ID 734] GALMLPHYNSR [SEQ ID 735] VFDGVLRPG [SEQ ID 736] LQSQND [SEQ ID 737] LQSQNDQRGEI [SEQ ID 738] QSQNDQRGEIIHVK [SEQ ID 739] RGEIIHVK [SEQ ID 740] RLQSQNDQ [SEQ ID 741] RLQSQNDQRG [SEQ ID 742] RLQSQNDQRGEIIH [SEQ ID 743] MPMP [SEQ ID 744] PMPL [SEQ ID 745] LEPDNR [SEQ ID 746] GIARLAGTSSVIN [SEQ ID 747] RSQNIF [SEQ ID 748] PNSM [SEQ ID 749] GHPM [SEQ ID 750] HPMS [SEQ ID 751] FLPQHTD [SEQ ID 752] EWQINEK [SEQ ID 753] GPQQYAEWQINEK [SEQ ID 754] PQQYAEWQ [SEQ ID 755] RGPQQYA [SEQ ID 756] HNPR [SEQ ID 757] WHN [SEQ ID 758] WDP [SEQ ID 759] HPSF [SEQ ID 760] PGQLQSFLLSGNQNQQNYLSGF [SEQ ID 761] QLQSFLLSGNQNQQNYLSGFSK [SEQ ID 762] QSFLLSGNQNQQ [SEQ ID 763] PGQLQSFLLSGN [SEQ ID 764] QSFLLSGNQ [SEQ ID 765] QNQQNYLSGFSK [SEQ ID 766] YLRGFS [SEQ ID 767] PVEMPTLLYPS [SEQ ID 768] RGPQQYAEWQINE [SEQ ID 769] GYVGLTFPGCPATHQQQFQLFEQR [SEQ ID 770] KNPQLQDLDIFVNYVEIK [SEQ ID 771] PGQLQSFLLSGNQNQQNYLSGFSK [SEQ ID 772] RGPQQYAEWQINEK [SEQ ID 773] VLDLAIPVNRPGQL [SEQ ID 774] RGPQQYAEWQINEK [SEQ ID 775] PROTEIN P02855 [SEQ ID 546-552] PEPTIDE: SRAIVIVTVNE PEPTIDE: AKLTPGDV PEPTIDE: IVIVTVNEGK PEPTIDE: LDALEPDNRIESEGGL (also in P02857) PEPTIDE: RPYYSNAPQE (also in P02857) PEPTIDE: LDALEPDNRIESEGGLIETWNPNNK (also in P02857) PEPTIDE: AIVIVTVNEGK (also in P13918) PROTEIN P02857 [SEQ ID 553-565 PEPTIDE: LQVVNCNGNTVFDGEL PEPTIDE: QVVNCNGNTVFDGEL PEPTIDE: IIAVPTGIVF PEPTIDE: GRRYRDRHQKVNRFRE PEPTIDE: RPYYSNAPQEI PEPTIDE: RLDALEPDNRIE PEPTIDE: RLDALEPDNRIESE PEPTIDE: LDALEPDNRIESEGGLIETW PEPTIDE: LDALEPDNRIE PEPTIDE: LDALEPDNRIESEGGLIE PEPTIDE: LDALEPDNRIESEGGL (also in P02855) PEPTIDE: RPYYSNAPQE (also in P02857) PEPTIDE: LDALEPDNRIESEGGLIETWNPNNK (also in P02855) PROTEIN P07728 [SEQ ID 566-609] PEPTIDE: VEHGLSLLQPYASLQEQEQGQVQSRER PEPTIDE: RSQNIFSGF PEPTIDE: GITGPTFPGCPESY PEPTIDE: CNGS PEPTIDE: SPREC PEPTIDE: PREC PEPTIDE: PRECR PEPTIDE: CPES PEPTIDE: SGCS PEPTIDE: CSNG PEPTIDE: RSQNIFSGFSTE PEPTIDE: VEEWSQNIFSGFST PEPTIDE: WSQNIFSGFSTEL PEPTIDE: WSQNIFSGFSTE PEPTIDE: STSQWQSSRR PEPTIDE: NRPI PEPTIDE: CDGS PEPTIDE: PRGC PEPTIDE: PRGCR PEPTIDE: RGCR PEPTIDE: GCRF PEPTIDE: PTFP PEPTIDE: PGCPE PEPTIDE: GCPE PEPTIDE: CPET PEPTIDE: AHWC PEPTIDE: HWCY PEPTIDE: SGCP PEPTIDE: SGCPN PEPTIDE: GCPN PEPTIDE: CPNG PEPTIDE: TFCTM PEPTIDE: FCTM PEPTIDE: FCTMR PEPTIDE: CTMR PEPTIDE: EGCA PEPTIDE: SQNIFSGFSTELL PEPTIDE: SQNIFSGFSTE PEPTIDE: QNDQRGEIVR PEPTIDE: SQNIFSGFSTEL (also in P07730) PEPTIDE: QLQCQNDQRGEI (also in P07730) PEPTIDE: LGQSTSQWQSSR (also in P07730) PEPTIDE: QQLLGQSTSQWQSSR (also in P07730) PEPTIDE: LLGQSTSQWQSSR (also in P07730) PROTEIN P07730 [SEQ ID 610-619] PEPTIDE: NDQRGEIVR PEPTIDE: GQSTSQWQSSR PEPTIDE: STSQWQSSR PEPTIDE: GITGPTFPGCPET PEPTIDE: GITGPTFPGCPETY PEPTIDE: SQNIFSGFSTEL (also in P07728) PEPTIDE: QLQCQNDQRGEI (also in P07728) PEPTIDE: LGQSTSQWQSSR (also in P07728) PEPTIDE: QQLLGQSTSQWQSSR (also in P07728) PEPTIDE: LLGQSTSQWQSSR (also in P07728) PROTEIN P09918 [620-630] PEPTIDE: IFFANQTYL PEPTIDE: EHLEPNLEGLTVEE PEPTIDE: IFFANQTYLPSETPAPLVHYREEELNNLRGDGTGER PEPTIDE: IHFEWDDDMGIPGAFYIK PEPTIDE: IFFANQTYLPSETPAPLVHYREEELNNLR PEPTIDE: TEQALPADLIK PEPTIDE: EHLEPNLEGLTVEEAIQNKK PEPTIDE: ISKEHLEPNLEGLTVEEAIQNKK PEPTIDE: LSLPHPQGDEHGAVSY PEPTIDE: ISKEHLEPNLEGLTVEEAIQNK PEPTIDE: EHLEPNLEGLTVEEAIQNK PROTEIN P0C1U8 [SEQ ID 631] PEPTIDE: LSTTGGNSGSPVFNEKNE PROTEIN P13918 [SEQ ID 632-639] PEPTIDE: QSFLLSGNQNQQNYLSG PEPTIDE: VLDLAIPVNRPGQLQS PEPTIDE: VLDLAIPVNRPGQLQSFL PEPTIDE: FLLSGNQNQQNYLSG PEPTIDE: FLLSGNQNQQNYLSGFSK PEPTIDE: DPQNPFIFKSNKFQTLFE PEPTIDE: ELAFPGSAQEVDRILENQK PEPTIDE: AIVIVTVNEGK (also in P02855) PROTEIN P14323 [SEQ ID 640-667] PEPTIDE: INAVAAKRLQSQNDQRGE PEPTIDE: NRAQQQQVYGSSIE PEPTIDE: PSTNPWHSPR PEPTIDE: CHGS PEPTIDE: CHGSM PEPTIDE: PWHS PEPTIDE: FREC PEPTIDE: RECR PEPTIDE: ECRF PEPTIDE: CRFD PEPTIDE: CRFDR PEPTIDE: CTGT PEPTIDE: FPGC PEPTIDE: FPGCP PEPTIDE: PGCP PEPTIDE: PGCPA PEPTIDE: PGCPAT PEPTIDE: GCPA PEPTIDE: CPAT PEPTIDE: ENFC PEPTIDE: NFCT PEPTIDE: NFCTI PEPTIDE: FCTI PEPTIDE: AQQQQVYGSSIEQH PEPTIDE: AQQQQVYGSSIEQHSGQNIFSGF PEPTIDE: AAKRLQSQNDQRGE PEPTIDE: QARSLKNNRGEE (also in P14614) PEPTIDE: FNPSTNPWHSPRQGS (also in Q0DEV5) PROTEIN P14614 [SEQ ID 668] PEPTIDE: QARSLKNNRGEE (also in P14323) PROTEIN Q0D7S0 [SEQ ID 669] PEPTIDE: AAASLPAFCNVDIPNGGGGVCYWLAR PROTEIN Q0DEV5 [SEQ ID 670-680] PEPTIDE: VAGSAPGIEGDEIAPLAK PEPTIDE: LGVAGSAPGIEGDEIAPLAKEN PEPTIDE: GSAPGIEGDEIAPLAKE PEPTIDE: VAGSAPGIEGDEIAP PEPTIDE: GVAGSAPGIEGDEIAPLAK PEPTIDE: GVAGSAPGIEGDEIAPLAKEN PEPTIDE: VAGSAPGIEGDEIAPLAKEN PEPTIDE: SAPGIEGDEIAPLAK PEPTIDE: GSAPGIEGDEIAPLAK PEPTIDE: SAPGIEGDEIAPLAKEN PEPTIDE: FNPSTNPWHSPRQGS (also in P14323) PROTEIN Q9M3X6 [SEQ ID 681-699] PEPTIDE: VDLVIPVNGPGK PEPTIDE: LVDLVIPVNGPGK PEPTIDE: IKLPAGTTSY PEPTIDE: IKLPAGTTSYL PEPTIDE: RRNPFLFKSNKF PEPTIDE: IENPVKELTFPGSVQEINR PEPTIDE: RRNPFLFKSNKFLT PEPTIDE: AKPHTIFLPQH IDA PEPTIDE: AKPHTIFLPQHIDAD PEPTIDE: KQKYRYQRE PEPTIDE: KQKYQYQRE PEPTIDE: MLPH PEPTIDE: RRNPFLFKSNKFLTLFENE PEPTIDE: PFLFKSNKFLTLFE PEPTIDE: SQERRNPFLFKSNKFLTLFE PEPTIDE: RRNPFLFKSNKFLTLFE PEPTIDE: SQERRNPFLFKSNKFLTLFENE PEPTIDE: LTFPGSVQE PEPTIDE: ELTFPGSVQEINR Rice Protein: Q0D9D0 MLCLTSSSSSAPAPLLPSLADRPSPGIAGGGGNVRLSVVSSPRRSWPGKVKTNFSVPATA RKNKTMVTVVEEVDHLPIYDLDPKLEEFKDHFNYRIKRYLDQKCLIEKHEGGLEEFSKGY LKFGINTVDGATIYREWAPAAQEAQLIGEFNNWNGAKHKMEKDKFGIWSIKISHVNGKPA IPHNSKVKFRFRHGGGAWVDRIPAWIRYATFDASKFGAPYDGVHWDPPACERYVFKHPRP PKPDAPRIYEAHVGMSGEEPEVSTYREFADNVLPRIRANNYNTVQLMAIMEHSYYASFGY HVTNFFAVSSRSGTPEDLKYLVDKAHSLGLRVLMDVVHSHASNNVTDGLNGYDVGQNTHE SYFHTGDRGYHKLWDSRLFNYANWEVLRFLLSNLRYWMDEFMFDGFRFDGVTSMLYHHHG INKGFTGNYKEYFSLDTDVDAIVYMMLANHLMHKLLPEATIVAEDVSGMPVLCRPVDEGG VGFDFRLAMAIPDRWIDYLKNKEDRKWSMSEIVQTLTNRRYTEKCIAYAESHDQSIVGDK TIAFLLMDKEMYTGMSDLQPASPTINRGIALQKMIHFITMALGGDGYLNFMGNEFGHPEW IDFPREGNNWSYDKCRRQWSLVDTDHLRYKYMNAFDQAMNALEEEFSFLSSSKQIVSDMN EKDKVIVFERGDLVFVFNFHPNKTYKGYKVGCDLPGKYRVALDSDALVFGGHGRVGHDVD HFTSPEGMPGVPETNFNNRPNSFKVLSPPRTCVAYYRVDEDREELRRGGAVASGKIVTEY IDVEATSGETISGGWKGSEKDDCGKKGMKFVFRSSDEDCK [SEQ ID 705] Rice protein: Q6AVS5 MDRYQRVERPRPESAIEENEIRITAQGLIRNYVSYATSLLQDRRIKEIVLKAMGQAISKS VAVAEIIKKRVPGLYQDTNISSVSITDVWEPIEEGLVPLEMTRHVSMISITLSPRDLDKN SPGYQTPVYVEQPRQQPRLQQAPPPPQRQVRQPPPDYEDSYVRGRGRGRGRGRGRGWGRG GYGGYGGYGNNQGGYNQGGGYYDNQGGYGGYDNQGGYGGYDNQGGYGGGGYGYNQGRYGN YQENGGYNRGRGGMRGRGNWNYRGGYERGRGGGFPGGRGYGGRGRGRMGGRGGRGN [SEQ ID 706] Rice Protein: Q8H920 MALEHLGRRNVAGSLLLLNLLMYVFLLGFAGWALNSSIKNAGADVGVGWGEQPWSPYYRQ SAWFASRFHLATFAALAGALGVAAKASAAYHGGRSGASWRPQGLAAAASLGTAAWAATAL AFGVACREIHDAAAAGPAGAARGWRMRALEGLTVTLAFTQLLYVLLLHAAVAGERCGLAC AADA [SEQ ID 707] Pea protein: O49927 MAIKTKLSLTIFLFFLLALLCSNLAVGRKEKDPELTTCKDQCDMQRQYDEEDKRICMERC DDYIKKKQERQKHKEHEEEEEQEQEEDENPYVFEDNDFETKIDTKDGRVLILNKFNEKSK LLKNIENYGLAVLEIKANAFLSPHHYDSEAILFNIKGRGIIGLVAEDRTERFNLEEGDIM RVPAGTPMYLVNRDENEKLYIAAFHMPPSSGSAPVNLEPFFESAGRKPESVLNTFSSKVL QAALKSSKGELETVLDEQKKGRIFKIEKEDVRGLAPKKSLWPFGGPFKSPFNIFSNNPAF SNKFGSLFEVGPSQEKSGLEGLNLMLTLANITKGSMSTIHYNTNANKIALVIDGEGELEM ACPHMPSSSSNSRQKKSSISYHNINAKLRPGVMFVVPAGHPFVNIASKKKNLIVVCFEVN AQRNKKLALAGKKNIVSALDKAAKEVAFDIAAEKVDEVFERKEEFFFPYDNEERKEEHGR AVV [SEQ ID 708] Pea protein: Q41000 MFRRATSTFLSRASATRRFSTDVATPATNSSFVEAWRKVSPNIDPPKTPLEFLKTRPPVP STIPTKLTVNFVLPYSSQLAAKEVDSVIIPATTGEMGVLPGHVATIAELKPGVLTVQEGT DTTKYFVSSGFRFIHANSVADIIAVEAVPVNQLDRDLVQKGLQEFTQKLNSATTDLEKRE AQIGIDVDSALNSALTG [SEQ ID 709] Rice Protein: P20698 MKIIFFFALLAIAACSASAQFDAVTQVYRQYQLQPHLMLQQQMLSPCGEFVRQQCSTVAT PFFQSPVFQLRNCQVMQQQCCQQLRMIAQQSHCQAISSVQAIVQQLRLQQFASVYFDQSQ AQAQAMLALNMPSICGIYPSYNTAPCSIPTVGGIWY [SEQ ID 710] Pea Protein: O04434 MQDSSTMKFSPLDLMTAIIKGKFNPSNDSSQAPASIIFENREFVMILTTSIAVLIGCVVV LIWRRSNSNKSKQIEVPKLVIKKLPELDVDDGKKKVTVFFGTQTGTAEGFAKAIAEEAKA RYEKAKFRVVDMDDYAADDDEYLEKLKRETMALFFLATYGDGEPTDNAARFYKWFTEEYE GEEDSFKNLSYGVFGLGNRQYEHFNKVAKVVDDKLLEQGGKRLVPVGLGDDDQCIEDDFT AWKEELWPALDQLLRDEDDTPVATPYTAAVSEYRVVIHDPLDATVDEKKRHNVNGHAVVD AQHPVRANVAVRRELHTPASDRSCTHLEFDISGTGVVYETGDHVGVYCENLSDTVEEAER ILGLSPDTYLSIHTDDEEGKPLGGSSLPPPFPPCTLRTALTKYADLLSSPKKSALVALAA HASDPSEADRLRHLASPAGKDEYAEWVISSQRSLLEVMAEFSSAKPPIGVFFAAVAPRLQ PRYYSISSSPRMAPSRIHVTCALVHDKMPTGRIHKGVCSTWMKNSVPLEKNQDCSWAPIF VRQSNFRLPADNKVPVIMIGPGTGLAPFRGFLQERLALKEDGAELGPSVLFFGCRNRQVD YIYEDELNHFVNGGALSELIVAFSRDGPTKEYVQHKMMEKASDIWNMISQGAYVYVCGDA KGMARDVHRTLHTILQEQGSLDSSKTESMVKNLQMTGRYLRDVW [SEQ ID 711] Rice Protein: Q5N725 MSAYCGKYKDELIKNAAYIGTPGKGILAADESTGTIGKRFASINVENVEENRRSLRELLF TTPGALQHLSGVILFEETLYQKTKDGKPFVDVLKEGGVLPGIKVDKGTVEVAGTNKETTT QGHDDLGKRCAKYYEAGARFAKWRAVLKIGPNEPSQLSIDLNAQGLARYAIICQENGLVP IVEPEILVDGSHDIERCAYVTEKVLAACYKALNEHHVLLEGSLLKPNMVTPGSESKKVSP QLIAEYTVRALQRTVPAAVPAIVFLSGGQSEEEATVNLNAMNKLSTKKPWALSFSFGRAL QQSTLKAWGGKTENVVKAQKAFITRCKANSEATLGTYQGDAVLGEGASESLHVKDYKY [SEQ ID 712] Pea Protein: B5A8N6 MASLQTQMISFYAIFLSILLTTILFFKVNSTETTSFLITKFSPDQQNLIFQGDGYTTKEK LTLTKAVKNTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYNVADGFTFFIAPV DTKPQTGGGYLGVFNSAEYDKTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTK SWKLQNGEEANVVIAFNAATNVLTVSLTYPNSLEEENVTSYTLSDVVSLKDVVPEWVRIG FSATTGAEYAAHEVLSWSFHSELSGTSSSKQAADA [SEQ ID 713] Rice Protein: Q6K508 MATTTSLLSSCLCALLLAPLFSQGVDAWESRQGASRQCRFDRLQAFEPLRKVRSEAGDTE YFDERNEQFRCAGVFVIRRVIEPQGLVVPRYSNTPALAYIIQGKGYVGLTFPGCPATHQQ QFQLFEQRQSDQAHKFRDEHQKIHEFRQGDVVALPASVAHWFYNGGDTPAVVVYVYDIKS FANQLEPRQKEFLLAGNNQRGQQIFEHSIFQHSGQNIFSGFNTEVLSEALGINTEASKRL QSQNDQRGDIIRVKHGLQLLKPTLTQRQEEHRQYQQVQYREGQYNGLDENFCTIKARVNI ENPSRADYYNPRAGRITLLNNQKFPILNLIGMGAARVNLYQNALLSPFWNINAHSVVYII QGSVRVQVANNQGRSVFNGVLHQGQLLIIPQNHAVIKKAEHNGCQYVAIKTISDPTVSWV AGKNSILRALPVDVIANAYRISRDEARRLKNNRADEIGPFTPRFPQKSQRGYQFLTEGLS LIGM [SEQ ID 714] PEA PROTEIN: Q712V4 QKAPRKQLATKAARKSAPATGGVKKPHRFRPGTVALREIRKYQKSTELLIRKLPFQRLVR EIAQDFKTDLRFQSSAVSALQEAAEAYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRG ERA [SEQ ID 715] Pea Protein: P09886 MAQSVSLSTIASPILSQKPGSSVKSTPPCMASFPLRRQLPRLGLRNVRAQAGGDGDNKDN SVEVHRVNKDDQGTAVERKPRRSSIDISPFGLLDPWSPMRSMRQMLDTMDRIFEDAITIP GRNIGGGEIRVPWEIKDEEHEIRMRFDMPGVSKEDVKVSVEDDVLVIKSDHREENGGEDC WSRKSYSCYDTRLKLPDNCEKEKVKAELKDGVLYITIPKTKIERTVIDVQ1Q [SEQ ID 716] Examples of homologs for each protein P13918 (Pea) >gi|137584|sp|P08438.1| VCL_VICFA RecNa me: Full = Vicilin; Flags: Precursor [Vicia faba] >gi|22057|emb|CAA68559.1| vicilin [Viciafaba var. minor] >gi|383931031|gb|AFH56916.1| vicilin [Vicia faba] MAATTLKDSFPLLTLLGIAFLASVCLSSRSDQDNPFVFESNRFQTLFENENGHIRLLQKFDQHSKLLENLQNYRLLEYKSKPHTIFLPQQTDADFIL VVLSGKAILTVLLPNDRNSFSLERGDTIKLPAGTIGYLVNRDDEEDLRVLDLVIPVNRPGEPQSFLLSGNQNQPSILSGFSKNILEASFNTDYKEIEK VLLEEHGKEKYHRRGLKDRRQRGQEENVIVKISRKQIEELNKNAKSSSKKSTSSESEPFNLRSREPIYSNKFGKFFEITPKRNPQLQDLNIFVNYVEI NEGSLLLPHYNSRAIVIVTVNEGKGDFELVGQRNENQQGLREEYDEEKEQGEEEIRKQVQNYKAKLSPGDVLVIPAGYPVAIKASSNLNLVGFGI NAENNQRYFLAGEEDNVISQIHKPVKELAFPGSAQEVDTLLENQKQSHFANAQPRERERGSQEIKDHLYSILGSF [SEQ ID 506] >gi|502105533|ref|XP_004492829.1| PREDICTED: vicilin-like isoform X1 [Cicer arietinum] ChickPea MAIKARFPLLVLLGIVFLASVCAKSDKENPFFFKSNNCQTLFENENGHVRLLQRFDKRSQLFENLQNYRLMEYNSKPHTLFLPQHNDADFILVVL RGRAILTVLNPNDRNTFKLERGDTIKLPAGTIAYLANRDDNEDLRVLDLAIPVNRPGQFQSFSLSGNENQQSYFQGFSKKILEASFNSDYEEIERV LLEEQEQKPEQRRGHKGRQQSQETDVIVKISREQIEELSKNAKSNCKKSVSSESEPFNLRSRSPIYSNRFGNFFEITPEKNPQLKDLDIFVNSVEIK EGSLLLPHFNSRATVILVVNEGKGEVELVGLRNENEQENKKEDEEEEEDRNVQVQRFQSKLSSGDVVVIPASHPFSINASSDLFLLGFGINAQN NQRNFLAGEEDNVISQIQRPVKEVAFPGSAEEVDRLLKNQRQSHFANAQPQQKRKGSQRIRSPF [SEQ ID 507] >gi|29539109|emb|CAD87730.1| allergen Len c 1.0101 [Lens culinaris] Lentil SRSDQENPFIFKSNRFQTIYENENGH1RLLQRFDKRSKIFENLQNYRLLEYKSKPHTIFLPQFTDADFILVVLSGKAILTVLNSNDRNSFNLERGDTI KLPAGTIAYLANRDDNEDLRVLDLAIPVNRPGQLQSFLLSGTQNQPSFLSGFSKNILEAAFNTEYEElEKVLLEEQEQKSQHRRSLRDKRQEITNE DVIVKVSREQIEELSKNAKSSSKKSVSSESEPFNLRSRNPIYSNKFGKFFEITPEKNPQLQDLDIFVNSVEIKEGSLLLPNYNSRAIVIVTVNEGKGDF ELVGQRNENQQEQREENDEEEGQEEETTKQVQRYRARLSPGDVLVIPAGHPVAINASSDLNLIGFG1NAKNNQRNFLAGEEDNVISQIQRPV KELAFPGSSREVDRLLTNQKQSHFANAQPLQIE [SEQ ID 508] Q9M3X6 (Pea) >gi|164512526|emb|CAP06312.1| cvc [Pisum abyssinicum] MATTVESRFPLLLFPGIIFLASVCVTYANYDEGSETRVPGQRERGRQEGEKEEKRHGEWRPSYEKEEDEEEKQKYRYQREKEDEEEKQKYRYQR EKKEEKEVQPGRERWEREEDEEQVDEEWRGSQRRQDPEERARLRHREERTKRDRRHKREGEEEERSSESQEQRNPFLFKSNKFLTLFENENG HIRRLQRFDKRSDLFENLQNYRLVEYRAKPHTIFLPQH1DADLILVVLNGKAILTVLSPNDRNSYNLERGDTIKIPAGTTSYLVNQDDEEDLRVVD FVIPVNRPGKFEAFGLSENKNQYLRGFSKNILEASLNTKYETIEKVLLEEQEKKPQQLRDRKRRQQGGERDAIIKVSREQIEELRKLAKSSSKKSLPS EFEPFNLRSHKPEYSNKFGKLFEITPEKKYPQLQDLDILVSCVEINKGALMLPHYNSRAIVVLLVNEGKGNLELLGLKNEQQEREDRKERNNEVQ RYEARLSPGDVVIIPAGHPVAISASSNLNLLGFGTNAENNQRNFLSGSDDN [SEQ ID 509] >gi|164512538|emb|CAP06318.1| cvc [Lathyrus annuus] MATTIKSRFPLLLLLGIIFLASVCVTWANYDEGSEPRVPGQRERGRQEGEKEEKRHGEWRPSYEEEYDEGLEPKVPGKRERGRQEGEKEEKRHE EWRPSYEKEEDEEEKQKYNYQREKKEHKEVQPGRERWERKQDEKQVEEDEEPGEEQWRGSKRHEDPEERARLRHREEKTKSYVEDNEETSS KEGRNPFLFKSNKFLTLFENENGHIRRLQRFDERSDIFENLQNYRLVEYRAKPHTMFLPQHIDADLILVVLNGKAILTVLSPNDRNSYNLERGDTV KLPAGTTSYLVNQDDEEDLRVVDLAIPVNRPGKFEAFGLSANKNQYLRGFSKNILEASLNTKYETIEKVLLEERRDQKGRQQGQETNAIVKVSRE QIEELRKLAKSSSKKSLLSESEPLNLRSQNPKYSNKFGKFFEITPQKKYPQLQDLDVSISCVEINKGALLLPHYNSRSIGILLVNEGKGNLELVGFKNE QQRQRENEETNKKLQRYEARLSSGDVVVIPEGHPVAISASSNLNLLGFGINAANNQRNFLTGSDDN [SEQ ID 510] >gi11645125581embICAP06328.11 cvc [Viciavillosa] MA-MKSRFPVLLLLGIIFLTSVCVTYANYDEGREPSVPGQRERGRQEGEKEEKRHGEWRPSEEDEEEKYKYEEGRVPGQRERGRQEGEKEEKR HGKWRPSEEEDEEEKYRYEEGSEPRGPGQRETGRQEGEKEKQRPEREPSYEKEEDEEEKQKYQYHREKKEQREVRPGRERFERHEDEEQWRG IQRHEDPEERARERYRAEIAKRQVEEEREERDIPHEREQRNPFLFKSNKFQTLFQNENGYIRRLQRFDKRSDLFENLQNYRLVEYRAKPHTIFLPQ HIDADLIIVVLSGRAILTVLSPDDRNSYNLERGDTIKLPAGTTSYLVNQDDEEDLRVVDLAIPVNRPGKVESFLLSGNKNQYLRGFSKNILEASFNT NYETIERVLLEEQDKESQQSIGQKRRSQRQETNALVKVSREQLEDLKRLAKSSSQEGLSSQFEPINLRSQNPKYSNKFGKVFEITPEKKYPQLQDL DLFVSSVDIKEGALMLPHYNSRAIVVLLVNEGRGNLELVGLKNEQQEQREKEDEQQERNNQVQRYEARLSPGDVVIIPAGHPVAVRASSDLNL LAFGINAENNQRNFLAGSDDN [SEQ ID 511] P09918 (Pea) >gi|357454557|ref|XP_003597559.1| Seed lipoxygenase-3 [Medicagotruncatula] >gi|355486607|gb|AES67810.1| seed linoleate 95-lipoxygenase [Medicagotruncatula] MFSGVTGILNRGHKIKGTVVLMRKNVLDINSLTSVGGVIGQGFDILGSTLDNLTAFLGRSVSLQLISATKPDANGKGKLGKATFLEGIITSLPTLG AGQSAFKIHFEWDDDMGIPGAFYIKNFMQTEFFLVSLTLEDIPNHGSIYFVCNSWIYNAKHHKLDRIFFANKAYLPSETPAPLVHYREEELNNLR GDGTGERKEWERIYDYDVYNDLGNPEKGDNHARPVLGGSDTYPYPRRGRTGRKPNPKDPKSESRSDFVYLPRDEAFGHLKSSDFLTYGLKAVS QNVVPALESVIFDLNFTPNEFDSFDEVHGLYEGGIKLPTDVLSKISPLPVLKEIFRTDGEQFLKYPPPKVLQVSRSAWMTDEEFAREMLAGVNPN VICCLQEFPPRSKLDSQVYGDHTSKITKEHLEPNLEGLTVEEAIQNKKLFLLDHHDSIMPYLRRINSTPTKAYATRTILFLSSDKTLKPLAIELSLPHP DGDEHGAVSHVYQPALEGVESTIWLLAKAYVVVNDSCYHQLVSHWLNTHAVVEPFVIATNRHLSYLHPIYKLLYPHYRDTMNINSLARQSLVN DGGIIEKTFLWGRYSMEMSSKVYKNWTLPGQALPADLIKRGMAIEEPSSPCGVKLVVEDYPYAHDGLEIWAAIKTWVQDYVSLYYTTDDILRQ DSELQAWWKELVEVGHGDKKNEPWWPKMQAREELVEVCTTVIWIASALHAAVNFGQYSYGGLILNRPTLSRRFMPEKGSAEYNELVKSPQ KAYLKTITPKFQTLIDLSVIEILSRHASDEVYLGERDNPNWTSDTRALEAFKKFGNKLAEIEKNLAQRNNDEKLRHRLGPVQMPYTLLHPSSEEGL TFRGI PNSISI [SEQ ID 512] >gi|734403888|gb|KHN32710.1| Seed linoleate 95-lipoxygenase-3 [Glycinesoja] MLGGLLHRGHKIKGTVVLMRKNVLDVNSVTSVGGIIGQGLDLVGSTLDTLTAFLGRSVSLQLISATKADANGKGKLGKATFLEGIITSLPTLGAG QSAFKINFEWDDGSGIPGAFYIKNFMQTEFFLVSLTLEDIPNHGSIHFVCNSWIYNAKLFKSDRIFFANQTYLPSETPAPLVKYREEELHNLRGDG TGERKEWERIYDYDVYNDLGDPDKGENHARPVLGGNDTFPYPRRGRTGRKPTRKDPNSESRSNDVYLPRDEAFGHLKSSDFLTYGLKSVSQN VLPLLQSAFDLNFTPREFDSFDEVHGLYSGGIKLPTDIISKISPLPVLKEIFRTDGEQALKFPPPKVIQVSKSAWMTDEEFAREMLAGVNPNLIRCL KDFPPRSKLDSQVYGDHTSQITKEHLEPNLEGLTVDEAIQNKRLFLLDHHDPIMPYLRRINATSTKAYATRTILFLKNDGTLRPLAIELSLPHPQGD QSGAFSQVFLPADEGVESSIWLLAKAYVVVNDSCYHQLVSHWLNTHAVVEPFIIATNRHLSVVHPIYKLLHPHYRDTMNINGLARLSLVNDGG VIEQTFLWGRYSVEMSAVVYKDWVFTDQALPADLIKRGMAIEDPSCPHGIRLVIEDYPYAVDGLEIWDAIKTWVHEYVFLYYKSDDTLREDPEL QACWKELVEVGHGDKKNEPWWPKMQTREELVESCAIIIWTASALHAAVNFGQYPYGGLILNRPTLSRRFMPEKGSAEYEELRKNPQKAYLKT ITPKFQTLIDLSVIEILSRHASDEVYLGERDNPNWTSDTRALEAFKRFGNKLAQIENKLSERNNDEKLRNRCGPVQMPYTLLLPSSKEGLTFRGIP NSISI [SEQ ID 513] >gi|593700103|ref|XP_007150490.1| hypothetical protein PHAVU_005G 157000g [Phaseolusvulgaris] >gi|561023754|gb|ESW22484.1| hypothetical protein PHAVU_005G157000g [Phaseolusvulgaris] MFSGVSGLINRGHKLKGTVVLMRKNVLDVNSVTSVGGIVGQGLDILGSTVDNLTAFLGRSVSLQLISATKPDANGKGKLGKATFLEGIITSLPTL GAGQSAFKIHFEWDDEMGIPGAFYIKNFMQTEFYLVSLTLEDIPNHGSLHFLCNSWIYNAKHFKNDRIFFVNQIYLPSETPAPLVKYREEELVN MRGDGTGERKEWDRIYDYDVYNDLGDPDKGENNARPILGGSDTLPYPRRGRTGRRPTRKDPKSESRSSDIYLPRDEAFGHLKSSDFLTYGLKS VSQNFLPALQSAFDLNFTPNEFDSFEEVHGLYSGGIKLPTDVLSKISPLPVLKEIFRTDGEQTLKFPPPKVVQDSKSAWMTDEEFAREMICGVNP NLIRLLQDFPPQSKLDSQVYGDHTSQITKENLEPNLEGLTVDEAIQSKRLFLLDHHDSIMPYLRRINATSSKAYATRTILFLKKDRTLKPLAIELSLP HPGGDKSGVVSQVFLPADEGVESSVWLLAKSYVIVNDSSYHQLVSHWLNTHAVVEPFVIATNRHLSVVHPIYKLLHPHYRDTMNINALARGD LVNHGGIIEKTFVWGRYSMEMSAVIYKDWVFTDQALPADLIKRGIATEDPECPHGLRLFIEDYPYAVDGLEIWDAIKTWVHEYVFLYYKSDDTL KEDPELQAWWKELVEVGHGDKKNEPWWPKMQTREELVEACSIVIWTASALHAAVNFGQYPYGGLILNRPTLSRRFMPEEGSAEYEELKKSP QKALLKTITPKFQTLVDLSVIEILSRHASDEVYLGERDNPNWTSDTRALEAFKRFGKKLSEIEKKLSQRNNDEKLRNRYGPVMMPYTLLFPSSDE GLTFRGIPNSISI [SEQ ID 514] P02857 (Pea) >gi|483449|emb|CAA83677.1| legumin A [Viciasativa] MAKLLALSLSFCFLLFSSCFALREQSQQNECQLERINALEPDNRIESEGGLIETWNPNNRQFRCARVALSRATLQRNALRRPYYSNAPQEIYIQQ GNGYFGMVFPGCPETHEEPQQSEQGEGRRYRDSHQKVNRFREGDIIAVPTGIAFWMYNDQDTPVIAISLTDTGSSNNQLDQMPRRFYLAG NQEQEFLRYQHQQGGKQEQDNDGNNIFSGFKRDFLEDAFNVNRHIVDRLQGRNEDEEKGAIVKVKGGLSIIAPPERQARHERGSRQEEDED EKEERQPSHHKSRRDEDEDDKEKRHSQKGQSRRQGDNGLEETVCTAKLRANIGSSPSPDIYNPQAGRIKTVTSLDLPVLRWLKLSAEHGSLHK NAMFVPHYNLNANSVIYALKGRARLQVVNCNGNTVFDGELEAGRALTVPQNYAVAAKSLSERFTYVAFKTDDRASIARLAGTSSVIDDLPLDV VAATFNMQRNEARQLKSNNPFKFLVPPRQSEMRASA [SEQ ID 515] >gi|600108|emb|CAA86824.1| legumin A precursor [Vicianarbonensis] MAKLLALSLSLCFLLFSNSFALREQSQQNECQLERLDALEPDNRIESEGGLIETWNPNNRQFRCAGVALSRVTLQRNALRRPYYSNAPQEIYIQQ GNGYFGVVFPGCPETFEEPQESEQRERRRYRDSHQKVNRFREGDIIAVPTGNVLWMYNDQDTPVIAISLTDTGSSNNQLDQIPRRFYLAGNQ EQEFLRYQREQGGKQEQENDGNNIFSGFKRDFLEDALNVNRHIVDRLQGRNEDEEKGAIVKVKGGLSIITPPERQRGSRQEEDEDEKEERQPS RRRDESQKGESRRHGDNGLEETVCTAKLRVNIGSSPSPDIYNPQAGRINTVTSLDLPVLRWLKLSAEHGSLRKNALIVPHYNRNANSVIYALKG RARLQVVNCNGNTVFDGELEAGRALTVPQNYAVAAKSLSERFTYVAFKTNDRDGIARLAGTSSVINDLPLDVVAATFNLQRNEARQLKSNNPF KLLVPPRESEKRASA [SEQ ID 516] >gi|502110016|ref|XP_004493779.1| PREDICTED: legumin-like [Cicerarietinum] MAKLLALSLSFCFLLFGSCFALRDQPEQNECQLEHLNALEPDNRIKSEGGLIETWNPSNKQFRCAGVALSRATLQPNSLRRPFYTNAPQEIFIQQ GNGYFGMVFPGCVETFEEPRESEQGEGSKFRDSHQKVNRFREGDIIAVPTGVVFWMFNDQDTPVIAVSLIDTSSFQNQLDQMPRRFYLAGN HEXXXXXXXXQQEGSEEEENEGGNIFSGFKRDFLEDALNVNRRIVNKLQGRNEDEEKGAIVKVKGGLSIITPPEKEPRQKRGSRQEEDEDEDEK RQPHRHSRQDEDEDEKRQPRRHSRGGSKSQRDNGFEETICTARLHQNIGSSSSPDIYNPQAGRIKTVTSFDLPALRFLKLSAEFGSLHKNAMFV PHYNLNANSILYALKGRARLQIVNCKGNSVFDGELEAGRALIVPQNFAIAAKSLSDRFSYVAFKTNDRAAIGRLLGASSLINGMPEEVVAAAFN MERNEARQLKFNSPFSFLVPPRSDSDNKAAA [SEQ ID 517] P02855 (Pea) >gi|164512536|emb|CAP06317.1| cvc [Lathyrushirsutus] MAIIIKSRFPLLLLLGIIFLASVCATWANYDEGSEPRVPGQRERGRQEGEKAEKSHEKWRPSYEEEYDEGSEPRVPGKRERGRQEGEKEEKRHGE WRPSHEEEYDEGSEPRVPTHGERGRQEGEKEEKRHEEWRPSYEKEEDEEEKEKYKYQREKKEQKEVQPGREKWERKQDEKHVEEDEDQEEE QWRGSKRREDPEERARLRYREERTKSNVEEETEERRNPFLFKSNKFLTLFENENGHIRRLQRFDERSDIFENLQNYRLVEYKAKPHTMFLPQHID ADLIIVVLNGKAILTVLSPNDRNSYNLERGDTIKLPAGTTSYLVNQDDEEDLRVVDLAIPVNRPGKFEAFGLSANKNQYLRGFSKNILEAFLNTKY ETIEKVLLEEQERRDRKGRQQGQETNAIVKVSREQIEELRKLAKSSSKKSLLSESEPINLRSQNPKYSNKFGKLFEITPEKKYPQLQDLDVSISCVEI NEGAPLLPHYNSRAIVLLLVNEGKGNLELVGFKNEQQRQRENEERNKKVQRYEARLSPGDVVVIPAGHPVAISASLNLNLVGFGVNAENNQR NFLTGSDDN [SEQ ID 518 >gi|164512542|emb|CAP06320.1| cvc [Lathyruscicera] MATIIKSRFPLLLLLGIIFLASVCVTLANYDEGSEPRVPAQRERGRQEGEKEEKRHGEWRPSHEKEYDEGSEPRVPGRRERGRQEGEKEEKRHGE WRPSYEKEYDEGSEPRVPGRRERGRQEGEKEEKRHGEWRPSYEKEYDEEEKQKYQYEREKEEQKEVQPGRERWERKEDEEKEEDQWRGSQ RHEDPEERARLRYRKERTKKYVEEDTEETSSESQGRRNPFLFKSNKFLTLFENENGYIRRLQRFDERSDIFENLQNYRLVEYRAKPHTIFLPQHIDA DLILVILNGKAILTVLSPNDRNSYNLERGDTIKLPAGTTSYLVNEDDEEDLRVVDLVIPVNRPGKFEAFDLNQYLGGFSKSVLEASLNTKYETIEKVL LEEQQKQGQETNAIVKVSREQIEELRKLAKSSSKKSLLSELEPVNLRSHSPKYSNKFGKFFEITPEKKYPQLQDLDVSISCVEINEGALLLPHYNSRA IVVVLVNEGKGNLELLGVQNEDEQQERKERNKEVQRYEARLSPGDVVIIPSGHPVAVSASSNLNLLGFGINAENNQRNFLSGSDDN [SEQ ID 519] >gi|164512544|emb|CAP06321.1| convicilin [Lathyrussativus] MATIIKSRFPLLLLLGIIFLASVCVTYANYDEGSEPRVPAQRERGRQEGEKEEKRHGEWRPSSEKEYDEGSEPRVPGRRERGRQEGEKEEKRHGE WRPSYEKEYDEEEKQKYQYEREKKEQKEVEPGRERWERKEDEEKEEDQWRGSQRHEDPEERARLRYRKERTKKYVEEDTEETSSESQGRRNP FLFKSNKFLTLFENENGYIRRLQRFDERSDLFENLQNYRLVEYRAKPHTIFLPQHIDADLILVILNGKAILTVLSPNDRNSYNLERGDTIKLPAGTTS YLVNEDDEEDLRVVDLVIPVNRPGKFEAFDLNQYLGGFSKSVLKASLNTKYETIEKVLLEEQQKQGQETNAIVKVSREQIEELRKLAKSSSKKSLLS ELEPVNLRSHSPKYSNKFGKFFEITPEKKYPQLQDLDVSISCVEINEGALLLPHYNSRAIVVLLVNEGKGNLELLGVQDEDEQQERKKRNKEVQRY EARLSPSDVVIIPAGHPVAVSASSNLNLLGFGINAENNERNFLSGSDDN [SEQ ID 520] D3VNE1 (Pea) >gi|357507721|ref|XP_003624149.1| Provicilin [Medicagotruncatula]  >gi|87162569|gb|ABD28364.1| Cupin, RmlC-type [Medicagotruncatula] >gi|355499164|gb|AES80367.1| vicilin 47 kDa protein [Medicagotruncatula] MAIKAPFQLLMLLGIFFLASVCVSSRDDRHDQENPFFFNANHFQTLFENENGHIRLLQRFDKRSKIFENLQNYRLLEYHSKPHTLFLPQHNDAD FlLAVLSGKAILTVLNPDNRNSFNLERGDTIKLPAGSIAYLANRDDNEDLRVLDLAIPVNRPGKFQSFSLSGSQNQQSFFSGFSKNILEAAFNANY EEIERVLIEEHEQEPQHRRGLRKDRRQQSQDSNVIVKVSREQIEELSRHAKSSSRRSGSSESAPFNLRSREPIYSNEFGNFFEITPEKNPQLKDLDIL VNYAEIREGSLLLPHFNSRATVIVVVDEGKGEFELVGQRNENQQEQREEDEQQEEERSQQVQRYRARLSPGDVYVIPAGHPTVVSASSDLSLL GFGINAENNERNFLAGEEDNVISQIERPVKEVAFPGSAQDVESLLKNQRQSYFANAQPQQREREEGRSQRQRELISSILGVF [SEQ ID 521] >gi|164512560|emb|CAP06329.1| convicilin [Viciaperegrina] MATTFKSRFSLLLLLGIIFLAFVCVTCANYDEGSEPRVPGQRERGRQEGEKEEQSRERHPQREPSREKEEDEEEKQKYDEGTEPRVPGQRERGR QEGEKEEQRRERHPGQREPSQEEDEEREESDRRQEGSSKSEEQRNPFLFKSNKFLTLFQNGNGHIRLLQRFDKRSDLFENLQNYRLLEYRAKPH TIFLPQHIDADLILVVLSGRAILTVLSPDDRNSYNLERGDTIKLPAGTTSYPLNQDDEEDLRVVDLAISVNRPGKVESFNLSGNKNQYLRGFSENIL EASFNTKYETIEKVLLEEQDKESQQPRGQRLQRQETNALVKVSREQVEELKRLARTSSKKGVSSEFEPFNLRSHGPKYSNKFGKFFEITPEKKYPQ LQDLDISVSSVEINEGALFLPHYNSRAIVVVLVDEGKGNLELVGFKNEQQEQREKEDEQEERNKQVQRYEAKLSPGDVVIIPAGHPVAVSASSN LNLLGFGINAENNQRNFLTGSDDN [SEQ ID 522] >gi|164512562|emb|CAP06330.1| convicilin [Vicialutea] MATTIKLRFPLLLLLGVILLASVCVTCANYDEGSEPRVPGRPEGEKEEKHRGKLRPSYEKEEDEGEKQRYHYEKKEQKEAQPRREKKEQKEEEKQ VEEESRESQRYEDPGERARERYRAEIIKRQVEKEREERDRRHQREGEEEEGSSKSRNPFLFKSNNFLTLFENENGHIRLLQRFDKRSDLFENLQNY RLVEYRAKPHTIFLPQHIDADLILVVLSGKAILTVLSPNNRNSYNLKRGDTIKLPAGTTSYLLNSDDEEDLRMVDLAISVNRPGKVESFNLSGNKN QYLRGFSKNILEASFNTKYETIEKVLLEEQDKESQQSIGQKRISQRQETNALVKVSREQIEEPKRLARSSSRKGVSSEFEPINLRSQRPKYSNKFGKF YEISPEKKYPQLQDLDVSVSSVEINEGALLLPHYNSRAIVTVLVNEGKGNLELIGFQNEQQGQREKEDEQQHERNKQVQRYDARLSSGDVVIIP AGHPVAVSASSNLDLLGFGINAENSQRNFLTGSDDN [SEQ ID 523] P07728 (Rice) >gi|531874314|gb|AGT59174.1| glutelin, partial [Oryzasativa Indica Group] CRFDRLQAFEPIRSVRSQAGTTEFFDVSNEQFQCTGVSAVRRVIEPRGLLLPHYTNGASLVYIIQGRGITGPTFPGCPESYQQQFQQSGQAQLT ESQSQSHKFKDEHQKIHRFRQGDVIALPAGVAHWCYNDGEVPVVAIYVTDLNNGANQLDPRQRDFLLAGNKRNPQAYRREVEERSQNIFSG FSTELLSEALGVSSQVARQLQCQNDQRGEIVRVEHGLSLLQPYASLQEQEQGQVQSRERYQEGQYQQSQYGSGCSNGLDETFCTMKVRQNI DNPNRADTYNPRAGRVTNLNTQNFPILNLVQMSAVKVNLYQNALLSPFWNINAHSVVYITQGRARVQVVNNNGKTVFNGELRRGQLLIIPQ HYAVVKKAQREGCAYIAFKTNPNSMVSHIAGKSSIFRALPNDVLANAYRISREEAQRLKHNRGDEFGAFTPIQYKSYQDVYNAAESS [SEQ ID 524] >gi|109894635|gb|ABG47337.1| glutelin precursor [Zizanialatifolia] MNMATINGPTIFFTVCLFLLCHGSLAQLLGQSTSQWQSSHRGSSRQCRFDRLQAFEPVRSVRSQAGTTEFFDASNELFQCAGVSIVRRIIEPRG LLLPQYTNGATIMYIIQGRGITGQTFPGCPESYQQQFQQSMQAQLTGSQSQSQKFKDEHQKINRFRQGDVIALPAGVAHWCYNDGEVPVVA IYVIDINNAANQLDPRQRDFLLAGNMRSPQAYRREVENQSQNIFSGFSAELLSEALGISTGVARQLQCQNDQRGEIVRVEHGLSLLQPYASLQE QEQKQEQPRERYQVTQHQQSQYGGGCSNGLDETFCAMRIWQNIDNPNLADTYNPRAGRVTNLNSQKFPILNLIQMSAVKVNLYQNALLSP FWNINSHSVVYVTQGCARVQVVNNNGKTVFNGELRRGQLLIIPQHYVVVKKAQREGCAYIAFKTNPNSMVSHIVGKSSIFRALPTDVLANAY RISREDAQRLKHNRGDELGAFTPLQYKSYQDVSSVAASS [SEQ ID 525] >gi|472867|emb|CAA52764.1| 11S globulin [Avenasativa] MATTSFPSMLFYFCIFLLFHGSMAQLFGQSSTPWQSSRQGGLRGCRFDRLQAFEPLRQVRSQAGITEYFDEQNEQFRCTGVSVIRRVIEPQGL VLPQYHNAPALVYILQGRGFTGLTFPGCPATFQQQFQPFDQSQFAQGQRQSQTIKDEHQRVQRFKQGDVVALPAGIVHWCYNDGDAPIVA IYVFDVNNNANQLEPRQKEFLLAGNNKREQQSGNNIFSGLSVQLLSEALGISQQAAQRIQSQNDQRGEIIRVSQGLQFLKPIVSQQVPGEQQV YQPIQTQEGQATQYQVGQSTQYQVGKSTPYQGGQSSQYQAGQSWDQSFNGLEENFCSLEARKNIENPQHADTYNPRAGRITRLNSKNFPIL NIVQMSATRVNLYQNAILSPFWNINAHSVIYMIQGHARVQVVNNNGQTVFNDILRRGQLLIVPQHFVVLKKAEREGCQYISFKTNPNSMVSH IAGKSSILRALPIDVLANAYRISRQEARNLKNNRGEEFGAFTPKLTQKGFQSYQDIEEGSSSPVRASE [SEQ ID 526] P14614 (Rice) >gi|115445309|ref|NP_001046434.1| Os02g0248800 [Oryzasativa Japonica Group]  >gi|37993738|gb|AAR06952.1| glutelin type-B [Oryzasativa Japonica Group] >gi|47497729|dbj|BAD19794.1|  glutelin type-B [Oryzasativa Japonica Group] >gi|113535965|dbj|BAF08348.1| Os02g0248800 [Oryzasativa Japonica Group]  >gi|215768942|dbj|BAH01171.1| unnamed protein product [Oryzasativa Japonica Group] >gi|284431772|gb|ADB84627.1|  glutelin [Oryzasativa Japonica Group] MTISVFSRFSIYFCVLLLCNGSMAQLFDPATNQWQTHRQGSFRECRFERLQAFEPLQNVRSEAGVTEYFDETNELFQCTGTFVIRRVIQPQGLL IPRYANTPGMVYIIQGRGSMGLTFPGCPATYQQQSQQFLFQGESQSQKFIDEHQKIHQFRQGDIVVLPTGVAHWFYNDGDTPVVALYVYDI NNSANQLEPRHREFLLAGKNNRVQQVYGRSIQQHSGQNIFNGFSVEPLSEALN1NTVTTKRLQSQNDQRGEIIHVKNGLQLLKPTLTQRQEQE QAQYQEVQYSEKPQTSSRWNGLEENLCTIKTRLNIENPSRADSYDPRAGRITSLDSQKFPILNIIQMSATRVNLYQNAILTPFWNVNAHSLMYV IRGRARVQVVSNFGKTVFDGVLRPEQLLIIPQNYVVLKKAQHEGCQYIAINTNANAFVSHLAGVDSVFHALPVDVIANAYCISREEARRLKNNR GDEYGPFPPRLQQQIYPEFSNESKGETSE[SEQ ID 527 >gi|428674402|gb|AFZ41188.1| glutelin, partial [Oryzasativa Japonica Group] LLCHGSMAQIFSLGINPWQNPRQGGSRECRFDRLQAFEPLRKVRHEAGVTEYFDEKNEQFQCTGTLVIRRIIEPQGLLLPRYSNTPGLVYIIQGT GVLGLTFPGCPATYQKQFRHFGLEGGSQRQGKKLRDENQKIHQFRQGDVVALPSGIPHWFYNEGDTPVVALFVFDVNNNANQLEPRQKEFL LAGNNIEQQVSNPSINKHSGQNIFNGFNTKLLSEALGVNIEVTRRLQSQNDRRGDIIRVKNGLRLIKPTITQQQEQTQDQYQQIQYHREQRSTS KYNGLDENFCAIRARLNIENPNHADTYNPRAGRITNLNSQKFSILNLVQMSATRVNLYQNAILSPFWNINAHSLVYTIQGRARVQVVSNHGKA VFNGVLRPGQLLIIPQNYVVMKKAELEGFQFIAFKTNPNAMVNHIAGKNSVLRAMPVDVIANAYRISRQEARSLKNNRGEEIGAFTPRYQQQ KIHQEYSNPNESETQ [SEQ ID 528] >gi|226510|prf| 11515394A seed storage globulin MATTRFPSLLFYSCIFLLCNGSMAQLFGQSFTPWQSSRQGGLRGCRFDRLQAFEPLRQVRSQAGITEYFDEQNEQFRCAGVSVIRRVIEPQGLL LPQYHNAPGLVYILQGRGFTGLTFPGCPATFQQQFQPFDQARFAQGQSKSQNLKDEHQRVHHIKQGDVVALPAGIVHWCYNDGDAPIVAV YVFDVNNNANQLEPRQKEFLLAGNNKREQQFGQNIFSGFSVQLLSEALGISQQAAQKIQSQNDQRGEIIRVSQGLQFLKPFVSQQGPVEHQA YQPIQSQQEQSTQYQVGQSPQYQEGQSTQYQSGQSWDQSFNGLEENFCSLEARQNIENPKRADTYNPRAGRITHLNSKNFPTLNLVQMSA TRVNLYQNAILSPYWNINAHSVMHMIQGRARVQVVNNHGQTVFNDILRRGQLLIIPQHYVVLKKAEREGCQYISFKTTPNSMVSYIAGKTSIL RALPVDVLANAYRISRQESQNLKNNRGEEFGAFTPKFAQTGSQSYQDEGESSSTEKASE [SEQ ID 529] P07730 (Rice) >gi|225959|prf| 11404367A glutelin MASTNRPIVFFTVCLFLLCDGSLAQQLLGQSTSQWQSSRRGSPRGCRFDRLQAFEPIRSVRSQAGTTEFFDVSNELFQCTGVSVVRRVIEPRGL LLPHYTNGASLVYIIQGRGITGPTFPGCPETYQQQFQQSGQAGLTESQSQSHKFKDEHQKIHRFRQGDVIALPAGVAHWCYNDCEVPVVAIYV TDINNGANQLDPRQRDFLLAGNKRNPQAYRREVEEWSQNIFSGFSTELLSEAFGISNQVARQLQCQNDQKGEIVRVERGLSLLQPYASLQEQ EQGQMQSREHYQEGGYQQSQYGSGCPNGLDETFCVNKVRQNIDNPNRADTYNPRAGRVTNLSQNFPILNLVQMSAVKVNLYQNTDTWIS MGQEENALLSPFWNINAHSIVYITQGRAQVQVLRRGQLLIVPQHYVVVKKAQREGCAYIAFKTNPNSMVSHIAGKSSIFRALPTDVLANAYRIS REEAQRLKHNRGDEFGAFTPLQYKSYQDVYNVAESS [SEQ ID 530] >gi|573943558|ref|XP_006654150.1| PREDICTED: glutelin type-A 3-like [Oryzabrachyantha] MKSSIVFSTICLVLLCHGSLAQLLSQSTSQWQSSRRGSPRQCRFDQLQAFEPIRTVRSQAGVTEFYDVSNELFQCTGVSVVRRVIEPRGLLLPHY SNGATLVYIIQGRGITGPTFPGCPETYQQQFQQSGEAQPFEGQSHKFRDEHQKIHRFRQGDVVALPAGVAHWCYNDGEVPIVAIYVTDIYNS ANQLDPRHRDFFLAGNNKVAQQLYRSEARENSKNIFGGFSVELLSEALGISRGVARQLQCQNDQRGEIVRVEHGLALLQPYASVQEQQQEQV QSRDYEQTQYQQKQPQGSCSNGLDETFCTMRLRQNIDNPNLADTYNPKAGRITYLNGQKFPILNLVQMSAVKVNLYQNAVLSPFWNINAHS VVYITQGRARVQVVNNNGKTVFDGELRQGQLLIIPQHHVVLKKAQREGCSYIALKTNPNSIVSHIAGKNSIFRALPGDVVTNAYRISREEAKRIK HNRGDESGVFAPSHAYRSYQDMSVAA [SEQ ID 531] >gi|721641733|ref|XP_010231907.1| PREDICTED: 12S seed storage globulin 1-like  [Brachypodiumdistachyon] MAHTSFSSFLSYFCLFLLFHGSMAQVLGQVSTWQSSRQGGSRDCSFDRLQAIEPVTQVRSQAGLTEYFDEQNEQFRCAGVFVIRRVIEPRGLL LPRYHNTPGLVYILQGNGFVGLTFPGCPETFREQFQQFRQTQSTLGQSQCQSQKLGDVHQRVHQFTQGDVVALPTGVAHWIYNGGDAPVV IVYVFDVNNNANQLEPRQKEFLLGGNYNGVLQYGQNIFSGFNAQLLSQAFGINEQTSQRIQNQNDGRGDIIRVDNGLQFLKPVVTQQQPEQ PFMPIQHQTGQSSRNGLEENFCSLEPRQNIEDPNRADTYNPRAGSITRLNGQNFPILNLVQMSATRVNLQKNAILSPFWNINAHSVVYVIQG HALVQVVNNQGHNVFNGLLHRGQLLIIPQNYVVLKKAESEGYQYIAFKTNANSMVSHIAGKNSILRALPVDVIANAYRISRQEAQNLKNNRGE ETGVLTPNFSQSTCQSYQTEDVQSLRPMSHWSE [SEQ ID 532] >gi|169244463|gb|ACA50505.1| seed allergenic protein RAG2 [Oryzasativa Japonica Group] MASNKVVFSALLLIIVSVLAATATMADHHKDQVVYSLGERCQPGMGYPMYSLPRCRAVVKRQCVGHGAPGGAVIDEQLRQDCCRQLAAVID DSWCRCSALNHMVGGIYRELGATDVGHPMAXVFPGCRRGIDLERAAASLPAFCNVIDIPNGTGGVCYWLGYPRTPRTGH [SEQ ID 533] >gi|5777592|emb|CAA44001.1| low molecular weight globulin [Oryzasativa] MASNKVVFSALLLIIVSVLRRDGTMADHHKDQVVYSLGERCQPGMGYPMYSLPRCRAVVKRQCVGHGAPGAVDEQLRQDCCRQLAAVDD SWCRCSALNHMVGGIYRELGATDVGHPMAEVFPGCRRGDLERAAASLPAFCNVDIPNGTGGVCYWLGYPRTPRTGH [SEQ ID 534] >gi|115471175|ref|NP_001059186.1| Os07g0214600 [Oryzasativa Japonica Group]  >gi|23616954|dbj|BAC20657.1| allergen RA16 [Oryzasativa Japonica Group] >gi|113610722|dbj|BAF21100.1|  Os07g0214600 [Oryzasativa Japonica Group] >gi|125557687|gb|EAZ03223.1| hypothetical protein Osl_25372 [Oryzasativa Indica Group] MASNKVVISALLVVVVSVLAATTTMADHHQEQVVYTPGQLCQPGIGYPTYPLPRCRAFVKRQCVAPGTVDEQVRRGCCRQLAAIDSSWCRC DALNHMLRI1YRESGAADAGHPMAEVFRGCRRGDIERAAASLPAFCNVDIPNGVGGVCYWLPGTGY [SEQ ID 535] Q0DEV5 (Rice) >gi|83375868|gb|ABC17777.1| waxy [Oryzarufipogon] MSALTTSQLATSATGFGIADRSAPSSLLRHGFQGLKPRSPAGGDATSLSVTTSARATPKQQRSVQRGSRRFPSVVVYATGAGMNVVFVGAEM APWSKTGGLGDVLGGLPPAMAANGHRVMVISPRYDQYKDAWDTSVVAEIKVADRYERVRFFHCYKRGVDRVFVDHPSFLEKVWGKTGEKI YGPDTGVDYKDNQMRFSLLCQAPRILNLNNNPYFKGTYGEDVVFVCNDWHTGPLASYLKNNYQPNGIYRNAKVAFCIHNISYQGRFAFEDYP ELNLSERFRSSFDFIDGYDTPVEGRKINWMKAGILEADRVLTVSPYYAEELISGIARGCELDNIMRLTGITGIVNGMDVSEWDPSKDKYITAKYD ATTAIEAKALNKEALQAEAGLPVDRKIPLIAFIGRLEEQKGPDVMAAAIPELMQEDVQIVLLGTGKKKFEKLLKSMEEKYPGKVRAVVKFNAPLA HLIMAGADVLAVPSRFEPCGLIQLQGMRYGTPCACASTGGLVDTVIEGKTGFHMGRLSVDCKVVEPSDVKKVAATLKRAIKVVGTPAYEEMV RNCMNQDLSWKGPAKNWENVLLGLGVAGSAPGIEGDEIAPLAKENVAAP [SEQ ID 536] >gi|297614332|gb|AD148504.1| glycogen synthetase [Oryzaofficinalis] MSALTTSQLATSATGFGIADRSAPSSLLRHGFQGLKPRSPAGGDASSLSVTTSARATPKQQRSVQRGSRRFPSVVVYATGAGMNVVFVGAEM APWSKTGGLGDVLGGLPPAMAANGHRVMVISPRHDQYKDAWDTSVVAEIKVADRYERVRFFHCYKRGVDRVFIDHPSFLEKVWGKTGEKI YGPDTGVDYKDNQMRFSLLCQAALEAPRILNLNNNPYFKGTYGEDVVFVCNDWHTGPLPSYLKNNYQPNGIYRNAKVAFCIHNISYQGRFAF EDYPELNLSERFRSSFDFIDGYDTPVEGRKINWMKAGILESDRVLTVSPYYAEELISGIARGCELDNIMRLTGITGIVNGMDVSEWDPSKDKYIA AKYDATTAIEAKALNKEALQAEAGLPVDRKIPLIAFIGRLEEQKGPDVMAAAIPELMQENVQIVLLGTGKKKFEKLLKSMEEKYPGKVRAVVKF NAPLAHLIMAGADVLAVPSRFEPCGLIQLQGMRYGTPCACASTGGLVDTVIEGKTGFHMGRLSVDCKVVEPSDVQKVATTLKRAIKIVGTPAY NEMVRNCMNQDLSWKGPAKNWENVLLGLGVAGSAPGVEGEEIAPLAKENVAAP [SEQ ID 537] >gi|389620054|gb|AFK93486.1| granule-bound starch synthase [Hordeumvulgare subsp. vulgare] MAALATSQLATSGTVLGVTDRFRRPGFQGLRPRNPADAALGMRTIGASAAPKQSRKAHRGSRRCLSVVVRATGSGMNLVFVGAEMAPWS KTGGLGDVLGGLPPAMAANGHRVMVVSPRYDQYKDAWDTSVISEIKVADEYERVRFFHCYKRGVDRVFIDHPWFLEKVRGKTKEKIYGPDA GTDYEDNQQRFSLLCQAALEAPRILNLNNNPYFSGPYGEDVVFVCNDWHTGLLACYLKSNYQSNGIYRTAKVAFCIHNISYQGRFSFDDFAQL NLPDRFKSSFDFIDGYDKPVEGRKINWMKAGILQADKVLTVSPYYAEELISDEARGCELDNIMRLTGITGIVNGMDVSEWDPTKDKFLAVNYDI TTALEAKALNKEALQAEVGLPVDRKVPLVAFIGRLEEQKGPDVMIAAIPEILKEEDVQIILLGTGKKKFEKLLKSMEEKFPGKVRAVVRFNAPLAH QMMAGADLLAVTSRFEPCGLIQLQGMRYGTPCVCASTGGLVDTIVEGKTGFHMGRLSVDCNVVEPADVKKVATTLKRAVKVVGTPAYQEM VKNCMIQDLSWKGPAKNWEDVLLELGVEGSEPGIVGEEIAPLAMENVAAP [SEQ ID 538] P14323 (Rice) >gi|573918992|ref|XP_006647120.1| PREDICTED: glutelin type-B 2-like [Oryzabrachyantha] MATTVFSRFSTYFCVLLLCHGSMAQLFNPSTNPWHNPRQGSSRECRFDRLQPFEPLRKVRSEAGVTEYFDEKNELFQCTGTFVIRRVIQPQGLL VPRYTNAPGLVYIIQGRGSIGLTFPGCPATYQQQFQQFLPQEQSQSQKFRDEHQKIHQFRQGDIVALPAGVAHWFYNDGDAPVVAVYVYDV KNSANQLEPRQREFLLGGNNMRAQQVYGSSAEQHSRQNIFSGFGVEILSEALGISTVTTKRLQSQNDQRGEIIHVKNGLQFLKPTLTQQQEQA QAQYQEVQYSEQQQTSSRWNGLDENFCTIKARMNIENTSRADTYNPRAGRTTSLNSQKFPILNLVQMSATRVNLYQNAILSTFWNVNAHSL VYTIQGRARVQVVSNFGKTVFDGELRPGQLLIIPQHYVVLKKAQREGFRYIAIKTNANAFVSQLVGKNSVFRSLPVDVIANVYRISREQARSLKN NRGEEHGAFAPRSQQQSYPGFSNQSESETSE [SEQ ID 539] >gi|573919041|ref|XP_006647142.1| PREDICTED: glutelin type-B 4-like [Oryzabrachyantha] MATTTFSRFSIYFCVLLLCHGSMAQLFSPTLNPWHSSRRGGSRDCRFDRLQAFEPLRRVRSEAGVTEYFDERNEQFQCTGTFVIRRVIEPQGLL VPRYTNTPGVVYIMQGRGSMGLTFPGCPATYQQQFQQFLPEGQSQSQKFRDEHQKIHQFRQGDIVALPAGVAHWFYNEGDTPVVALYVFD INNSANQLEPRQKDFLLAGNNNREQQVYGRSIEKHSGQN1FSGFNHELLSEALGISTLAAKRLQGQNDHRGEIIRVRNGLQLLKPTFTQQQEQ AQSQYQVQYSEKQQESTRCNGLDENFCTINARLNIENPSRADTYNPRAGRITHLNNQKFPILNLVQMSATRVNLYQNAILSPYWNVNAHSLV YMVQGHARVQVVSNLGKTVFNSVLRPGQLLIIPQHYVVLKKAEREGCQYIAFKTNANSIVSQLAGKNSILRAMPVDVVANAYRISREQARDLK NNRGEELGAFTPKFEQQSYPGLSNESESEASE [SEQ ID 540] >gi|109894635|gb|ABG47337.1| glutelin precursor [Zizanialatifolia] MNMATINGPTIFFTVCLFLLCHGSLAQLLGQSTSQWQSSHRGSSRQCRFDRLQAFEPVRSVRSQAGTTEFFDASNELFQCAGVSIVRRIIEPRG LLLPQYTNGATIMYIIQGRGITGQTFPGCPESYQQQFQQSMQAQLTGSQSQSQKFKDEHQKINRFRQGDVIALPAGVAHWCYNDGEVPVVA IYVIDINNAANQLDPRQRDFLLAGNMRSPQAYRREVENQSQNIFSGFSAELLSEALGISTGVARQLQCQNDQRGEIVRVEHGLSLLQPYASLQE QEQKQEQPRERYQVTQHQQSQYGGGCSNGLDETFCAMRIWQNIDNPNLADTYNPRAGRVTNLNSQKFPILNLIQMSAVKVNLYQNALLSP FWNINSHSVVYVTQGCARVQVVNNNGKTVFNGELRRGQLLIIPQHYVVVKKAQREGCAYIAFKTNPNSMVSHIVGKSSIFRALPTDVLANAY RISREDAQRLKHNRGDELGAFTPLQYKSYQDVSSVAASS [SEQ ID 541] P29835 (Rice) >gi|226508602|ref|NP_001152635.1| globulin precursor [Zeamays] >gi|195658363|gb|ACG48649.1|  globulin precursor [Zeamays] MAKIAAAAAAAAALCFAALVAVAVCQGEVERQRLRDLQCWQEVQESPLDACRQVLDRQLTGGGVGGPFRWGTGLRMRCCQQLQDVSRE CRCAAIRSMVRGYEEAMPPLEKGWWPWGRQQQPPPQGGGGGQGGYYYPCSRAGEGYQTQMYPPCRPGTTGPRIGRVRLTKAREYAAGL PMMCRLSEPQECSIFSGGDQY [SEQ ID 542] >gi|242090997|ref|XP_002441331.1| hypothetical protein SORBIDRAFT_09g024570 [Sorghumbicolor] >gi|241946616|gb|EES19761.1| hypothetical protein SORBIDRAFT_09g024570 [Sorghumbicolor] MAKIAAVAATAALCLAALVAVAVGQGVVERQRLKDLQCWQEVQENPLGACRQVLDRQLTGGMRYGIGPFRWGTGLRMRCCQQLQDVSR ECRCAAIRSMVRGYEETMPPLEKGWWGQQPQPGYDYPCSQAGEGYGYGESGQQQMYPPCRPGTGQKIARVKLTKARQYAAGMPMMCR LSEPQECSVFSGGDQYY [SEQ ID 543] >gi|514748428|ref|XP_004961615.1| PREDICTED: 19 kDa globulin-like [Setariaitalica] MAKFVVAAATAALCLAALVAMAAGQSGFERQRLRDLRCQREVEENPLWACRQVLDRQLTGGMRYGVGPFRWGTGLRMRCCQQLQDVS RECRCSAVRRMVRGYEEAMPPLEEGPYGYGGEQGEGYYGGGEGGEGYLPFPPRRIGRVRLTKARQYAAGLPMMCRLEPQECSVFSGDQYK [SEQ ID 544] P0C1U8 (Bacterial) GLUC (Staphylococcusaureus) >gi|446599182|ref|WP_000676528.1| glutamyl endopeptidase [Staphylococcus aureus]  >gi|253729369|gb|EES98098.1| trypsin [Staphylococcusaureus subsp. aureus TCH130] >gi|341844549|gb|EGS85761.1|  glutamyl endopeptidase [Staphylococcusaureus subsp. aureus 21259] >gi|537390486|gb|AGU61109.1|  Glutamyl endopeptidase precursor [Staphylococcusaureus subsp. aureus CN1] >gi|564714561|gb|ETD14665.1|  glutamyl endopeptidase [Staphylococcus aureus subsp. aureus KPL1845] >gi|577466329|gb|EUG79766.1|  glutamyl endopeptidase [Staphylococcusaureus M0139] >gi|580560623|gb|EVF84961.1| glutamyl endopeptidase [Staphylococcusaureus CoA56020] >gi|580687002|gb|EVH10169.1| glutamyl endopeptidase [Staphylococcusaureus UCIM6080] >gi|751815683|gb|KIN24957.1| glutamyl endopeptidase [Staphylococcusaureus MRSA_CVM43477] >gi|781884797|dbj|BAR08486.1| glutamyl endopeptidase precursor [Staphylococcusaureus subsp. aureus] >gi|781887762|dbj|BAR11210.1| glutamyl endopeptidase precursor [Staphylococcusaureus subsp. aureus] MKGKFLKVSSLFVATLTTATLVSSPAANALSSKAMDNHPQQSQSSKQQTPKIQKGGNLKPLEQREHANVILPNNDRHQITDTTNGHYAPVTYi QVEAPTGTFIASGVVVGKDTLLTNKHVVDATHGDPHALKAFPSAINQDNYPNGGFTAEQITKYSGEGDLAIVKFSPNEQNKHIGEVVKPATMS NNAETQVNQNITVTGYPGDKPVATMWESKGKITYLKGEAMQYDLSTTGGNSGSPVFNEKNEVIGIHWGGVPNEFNGAVFINENVRNFLKQ NIEDIHFANDDQPNNPDNPDNPNNPDNPNNPDEPNNPDNPNNPDNPDNGDNNNSDNPDAA [SEQ ID 545]